<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6213446</article-id><article-id pub-id-type="doi">10.3390/nu10101561</article-id><article-id pub-id-type="publisher-id">nutrients-10-01561</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Polyunsaturated Fatty Acids and Their Potential Therapeutic Role in Cardiovascular System Disorders&#x02014;A Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Soko&#x00142;a-Wysocza&#x00144;ska</surname><given-names>Ewa</given-names></name><xref ref-type="aff" rid="af1-nutrients-10-01561">1</xref></contrib><contrib contrib-type="author"><name><surname>Wysocza&#x00144;ski</surname><given-names>Tomasz</given-names></name><xref ref-type="aff" rid="af2-nutrients-10-01561">2</xref></contrib><contrib contrib-type="author"><name><surname>Wagner</surname><given-names>Jolanta</given-names></name><xref ref-type="aff" rid="af2-nutrients-10-01561">2</xref><xref ref-type="aff" rid="af3-nutrients-10-01561">3</xref></contrib><contrib contrib-type="author"><name><surname>Czy&#x0017c;</surname><given-names>Katarzyna</given-names></name><xref ref-type="aff" rid="af4-nutrients-10-01561">4</xref><xref rid="c1-nutrients-10-01561" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Bodkowski</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="af4-nutrients-10-01561">4</xref></contrib><contrib contrib-type="author"><name><surname>Lochy&#x00144;ski</surname><given-names>Stanis&#x00142;aw</given-names></name><xref ref-type="aff" rid="af3-nutrients-10-01561">3</xref><xref ref-type="aff" rid="af5-nutrients-10-01561">5</xref></contrib><contrib contrib-type="author"><name><surname>Patkowska-Soko&#x00142;a</surname><given-names>Bo&#x0017c;ena</given-names></name><xref ref-type="aff" rid="af4-nutrients-10-01561">4</xref></contrib></contrib-group><aff id="af1-nutrients-10-01561"><label>1</label>The Lumina Cordis Foundation, Szymanowskiego Street 2/a, 51-609 Wroclaw, Poland; <email>sokola@libero.it</email></aff><aff id="af2-nutrients-10-01561"><label>2</label>FLC Pharma Ltd., Wroclaw Technology Park Muchoborska Street 18, 54-424 Wroclaw, Poland; <email>tomasz.wysoczanski@gmail.com</email> (T.W.); <email>jolanta.pekala@flcpharma.com</email> (J.W.)</aff><aff id="af3-nutrients-10-01561"><label>3</label>Department of Bioorganic Chemistry, Faculty of Chemistry, University of Technology, Wybrzeze Wyspianskiego Street 27, 50-370 Wroclaw, Poland; <email>stanislaw.lochynski@pwr.edu.pl</email></aff><aff id="af4-nutrients-10-01561"><label>4</label>Institute of Animal Breeding, Faculty of Biology and Animal Sciences, Wroclaw University of Environmental and Life Sciences, Chelmonskiego Street 38c, 50-001 Wroclaw, Poland; <email>robert.bodkowski@upwr.edu.pl</email> (R.B.); <email>bozena.patkowska-sokola@upwr.edu.pl</email> (B.P.-S.)</aff><aff id="af5-nutrients-10-01561"><label>5</label>Institute of Cosmetology, Wroclaw College of Physiotherapy, Kosciuszki 4 Street, 50-038 Wroclaw, Poland</aff><author-notes><corresp id="c1-nutrients-10-01561"><label>*</label>Correspondence: <email>katarzyna.czyz@upwr.edu.pl</email>; Tel.: +48-71-320-5781</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>10</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2018</year></pub-date><volume>10</volume><issue>10</issue><elocation-id>1561</elocation-id><history><date date-type="received"><day>23</day><month>8</month><year>2018</year></date><date date-type="accepted"><day>19</day><month>10</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Cardiovascular diseases are described as the leading cause of morbidity and mortality in modern societies. Therefore, the importance of cardiovascular diseases prevention is widely reflected in the increasing number of reports on the topic among the key scientific research efforts of the recent period. The importance of essential fatty acids (EFAs) has been recognized in the fields of cardiac science and cardiac medicine, with the significant effects of various fatty acids having been confirmed by experimental studies. Polyunsaturated fatty acids are considered to be important versatile mediators for improving and maintaining human health over the entire lifespan, however, only the cardiac effect has been extensively documented. Recently, it has been shown that omega-3 fatty acids may play a beneficial role in several human pathologies, such as obesity and diabetes mellitus type 2, and are also associated with a reduced incidence of stroke and atherosclerosis, and decreased incidence of cardiovascular diseases. A reasonable diet and wise supplementation of omega-3 EFAs are essential in the prevention and treatment of cardiovascular diseases prevention and treatment.</p></abstract><kwd-group><kwd>cardiovascular system</kwd><kwd>omega-3 fatty acids</kwd><kwd>alpha-linoleic acid (ALA)</kwd><kwd>eicosapentaenoic acid (EPA)</kwd><kwd>docosahexaenoic acid (DHA)</kwd><kwd>lipids</kwd><kwd>nutrition</kwd></kwd-group></article-meta></front><body><sec id="sec1-nutrients-10-01561"><title>1. Introduction</title><p>Fatty acids are considered to be a fundamental building material for the structural components of cells, tissues, and organs as well as for the synthesis of certain biologically active substances. In scientific and medical fields, omega-3 fatty acids are characterized by multidirectional effects in humans: they present anticoagulant and antihypertensive properties, regulate lipid metabolism, and support central nervous system functioning and eyesight. Omega-3 fatty acids also present a wide scope of anti-inflammatory properties, which makes them efficient agents for use in patients presenting various disorders or inflammation-based health conditions. Some researchers have also suggested that omega-3 fatty acids may have an important role in the prevention of various types of cancer [<xref rid="B1-nutrients-10-01561" ref-type="bibr">1</xref>,<xref rid="B2-nutrients-10-01561" ref-type="bibr">2</xref>]. This paper introduces the biological significance and health promoting effect of the omega-3 fatty acids family with great focus on the cardiovascular system and its disorders.</p><p>Although there has been great progress in the prevention of cardiovascular diseases (CVDs), circulatory system disorders and heart failures are still the leading cause of death globally. It is well known that proper eating habits, regular physical activity, elimination of smoking, and low body weight are essential factors in cardiovascular risk reducing, but despite this common knowledge, CVDs are still the major cause of death worldwide, causing 17.3 million deaths per year (reported by the World Heart Federation in the Urbanization and Cardiovascular Disease report) [<xref rid="B3-nutrients-10-01561" ref-type="bibr">3</xref>].</p><p>At the beginning of the 20th century, cardiovascular diseases were responsible for nearly 10% of all deaths globally. Now, early in the 21st century, they account for nearly one half of all deaths in the developed world and 25% of all deaths in developing countries. Similar data was presented by the World Health Organization as a result of the Global Burden of Diseases Study, which stated that three out of every ten deaths in Europe in patients younger than 65 years old were due to cardiovascular system diseases [<xref rid="B4-nutrients-10-01561" ref-type="bibr">4</xref>].</p><p>Exposure to certain cardiovascular disease risk factors is highly affected by socioeconomic status and the environment in which an individual lives, which means that the majority of CVDs result from risk factors that may be controlled, treated, or modified, which include high blood pressure, cholesterol, diabetes, tobacco use, lack of physical activity, and overweight/obesity.</p><p>Consequently, there is enough evidence to conclude that a healthy diet and lifestyle are our best weapons in the fight against cardiovascular diseases and the most effective means in which to prevent the occurrence of CVDs in society. A case study showed that mortality due to ischaemic heart disease and prevalence of coronary arteriosclerosis were low in Greenlandic Inuit (Greenlanders). Since the first description of the so-called Inuit paradox in the 1970s, the number of studies and publications associating polyunsaturated fatty acids intake with lower risk of cardiac disorders has grown extensively [<xref rid="B5-nutrients-10-01561" ref-type="bibr">5</xref>,<xref rid="B6-nutrients-10-01561" ref-type="bibr">6</xref>,<xref rid="B7-nutrients-10-01561" ref-type="bibr">7</xref>].</p><p>In the world of cardiology research, remarkably wide recognition in this matter has been obtained as a result of the trials carried out by GISSI (Gruppo Italiano per la Studio della Sopravvivenza nell&#x02019;Infarto miocardico)&#x02014;an Italian group studying survival of acute myocardial infarction (AMI). The GISSI designed and carried out a series of large-scale clinical trials that involved more than 60,000 patients over the last 20 years. One of the research studies&#x02014;the GISSI Preventzioni trial evaluated the effectiveness of a therapy with omega-3 polyunsaturated fatty acids (PUFAs), vitamin E, and a statin in patients with a previous AMI and demonstrated 20% mortality reduction in patients treated with omega-3 PUFAs. Another study demonstrated that omega-3 ethyl esters have clinically proven benefits in improving post-myocardial infarction (MI) outcomes, such as significant 15% risk reduction for all-cause mortality together with 20% risk reduction for CVDs [<xref rid="B8-nutrients-10-01561" ref-type="bibr">8</xref>,<xref rid="B9-nutrients-10-01561" ref-type="bibr">9</xref>]. The in-hospital mortality due to AMI has been reduced by approximately 30% over the last 20 years [<xref rid="B10-nutrients-10-01561" ref-type="bibr">10</xref>]. According to the current guidelines of the European Society of Cardiology, treatment with omega-3 PUFAs may be considered a new option to add to the shortlist of evidence-based life-prolonging therapies for heart failure [<xref rid="B11-nutrients-10-01561" ref-type="bibr">11</xref>].</p></sec><sec id="sec2-nutrients-10-01561"><title>2. Results</title><sec id="sec2dot1-nutrients-10-01561"><title>2.1. Classification of Unsaturated Fatty Acids</title><p>Unsaturated fatty acids (UFAs) are classified as either monounsaturated fatty acids (MUFAs), because they have only one double bond (e.g., omega-7 and -9 fats), or polyunsaturated fatty acids (PUFAs), since they have more than one double bond in their backbone (e.g., omega-3 and -6 acids) [<xref rid="B12-nutrients-10-01561" ref-type="bibr">12</xref>]. The most important role and significant functions are attributed to PUFAs, which possess a unique subgroup referred to essential fatty acids (EFAs), cannot be synthesized de novo and like vitamins, and need to be delivered with food. They can be further classified in various groups due to their chemical structure. Omega fatty acids are classified according to the location of the first double bond&#x02014;the difference between them is expressed by the number of omega [<xref rid="B13-nutrients-10-01561" ref-type="bibr">13</xref>]. Two main compound groups can be distinguished among PUFAs: omega-3 and omega-6 families. The first double bond in the omega-3 family occurs at the third carbon from the methyl end of the chain (hence the name omega-3), and in the case of the omega-6 family, the first double bond occurs at the sixth carbon from the methyl end of the chain (<xref ref-type="fig" rid="nutrients-10-01561-f001">Figure 1</xref>).</p><p>Alpha-linolenic acid (ALA, 18:3, n-3), eicosapentaenoic acid (EPA, 20:5, n-3), and docosahexaenoic acid (DHA, 22:6, n-3) are the prominent representatives of the omega-3 family (<xref ref-type="fig" rid="nutrients-10-01561-f001">Figure 1</xref>). ALA is a precursor of the omega-3 family (<xref ref-type="fig" rid="nutrients-10-01561-f002">Figure 2</xref>) and also the only omega-3 that must be derived from the diet, since it cannot be produced by the human body. Regarding food sources, it is found in vegetable oils such as flaxseed (linseed), canola (rapeseed), soybean, and hemp oil, nuts, such as walnuts, as well as in seeds (e.g., chia (<italic>Salvia hispanica</italic>)), dairy products, eggs, and algae [<xref rid="B14-nutrients-10-01561" ref-type="bibr">14</xref>,<xref rid="B15-nutrients-10-01561" ref-type="bibr">15</xref>,<xref rid="B16-nutrients-10-01561" ref-type="bibr">16</xref>,<xref rid="B17-nutrients-10-01561" ref-type="bibr">17</xref>]. Omega-3 fatty acids can also be found in the meat of free-ranged animals (herbivores and carnivores).</p><p>ALA serves as a precursor compound to the synthesis of other omega-3 fatty acids [<xref rid="B18-nutrients-10-01561" ref-type="bibr">18</xref>]. Although EPA and DHA can also be delivered with food, ALA can be converted to EPA and DHA in the body and therefore has the ability to control their physiological activity. EPA and DHA are commonly found in fish and seafood, especially in fatty fish oils, squid and krill oil, egg oil, and seaweed, hence eicosapentaenoic and docosahexaenoic acids are frequently called &#x0201c;marine omega-3s&#x0201d; [<xref rid="B19-nutrients-10-01561" ref-type="bibr">19</xref>]. High concentration of these molecules is not fortuitous; their role is to protect these marine organisms from their body fluids solidifying at low temperatures [<xref rid="B20-nutrients-10-01561" ref-type="bibr">20</xref>].</p><p>Omega-6s are represented by the parent compound linoleic acid (LA, 18:2, n-6) (<xref ref-type="fig" rid="nutrients-10-01561-f001">Figure 1</xref>). The human body is not capable of producing LA, thus next to omega-3 alpha-linoleic acid, LA constitutes another essential fatty acid that has to be delivered with diet. Once linoleic acid is ingested, it is converted in a few steps into arachidonic acid (AA, 20:4, n-6) (<xref ref-type="fig" rid="nutrients-10-01561-f002">Figure 2</xref>). The most significant dietary plant sources of omega-6s are corn, soybean, and sunflower oil, as well as nuts, including coconut together with coconut oil, almonds, pine-nuts, and hazelnuts. Animal origin products that are considered to be good sources of omega-6s include, for example, pork, lard, turkey fat, and butter [<xref rid="B21-nutrients-10-01561" ref-type="bibr">21</xref>].</p><p>It has been established that PUFAs are required for the normal development and functioning of the brain and heart, and also for the equilibrium of all tissues and organs. Studies concerning the nutritional deficiency of omega-3 fatty acids as well as the particular roles of omega-6 and omega-3 have become the focus of numerous research groups around the world [<xref rid="B22-nutrients-10-01561" ref-type="bibr">22</xref>,<xref rid="B23-nutrients-10-01561" ref-type="bibr">23</xref>,<xref rid="B24-nutrients-10-01561" ref-type="bibr">24</xref>,<xref rid="B25-nutrients-10-01561" ref-type="bibr">25</xref>,<xref rid="B26-nutrients-10-01561" ref-type="bibr">26</xref>]. Deficit of omega-6 linoleic acid leads to poor growth, fatty liver, skin lesions, and reproductive failure, while the symptoms of omega-3 fatty acids deficiency include reduced vision or abnormal electroretinogram results. Studies in rodents have revealed significant effects of n-3 PUFAs deficiency on learning, memory, cognition, and behavior [<xref rid="B27-nutrients-10-01561" ref-type="bibr">27</xref>]. The literature reports highlight how the increment of the omega-6/omega-3 ratio corresponds to an increase in the occurrence of pro-inflammatory conditions. It is crucial to maintain a proper balance of omega-3 in our bodies, since an excess of omega-6 leads to low grade chronic systemic inflammation&#x02014;recognized as the leading cause of the so-called civilizational diseases [<xref rid="B28-nutrients-10-01561" ref-type="bibr">28</xref>,<xref rid="B29-nutrients-10-01561" ref-type="bibr">29</xref>,<xref rid="B30-nutrients-10-01561" ref-type="bibr">30</xref>,<xref rid="B31-nutrients-10-01561" ref-type="bibr">31</xref>,<xref rid="B32-nutrients-10-01561" ref-type="bibr">32</xref>].</p></sec><sec id="sec2dot2-nutrients-10-01561"><title>2.2. EFAs Conversion</title><p>The concentration of fatty acids in blood reflects both dietary intake and biological processes. When omega-3 and omega-6 PUFAs are consumed, they compete for incorporation into cell membranes in all tissues of the body. Omega-3 and omega-6 fatty acids precursors, i.e., ALA and LA, strive for the same metabolic pathways in the synthesis of longer polyunsaturated fatty acids (such as AA, EPA, and DHA) and for the availability of the same elongase and desaturase enzymes, particularly for &#x00394;6-desaturase. It has been observed that too high an intake of LA would reduce the level of &#x00394;6-desaturase available for the metabolism of ALA [<xref rid="B18-nutrients-10-01561" ref-type="bibr">18</xref>,<xref rid="B32-nutrients-10-01561" ref-type="bibr">32</xref>].</p><p>The first step of this process involves ALA conversion into EPA, which is an active metabolic product. This is performed through a double bond formation at the sixth and fifth position (by &#x02206;6- and &#x02206;5-desaturase catalysis) and double bond elongation at the sixth position (&#x02206;6-elongase). Then, EPA can be metabolized into DHA via &#x02206;5-elongation and &#x02206;4-desaturation [<xref rid="B22-nutrients-10-01561" ref-type="bibr">22</xref>]. The above process is limited, and the only organs capable of these conversions include the liver, cerebrovascular lumen, and astroglial cells [<xref rid="B33-nutrients-10-01561" ref-type="bibr">33</xref>,<xref rid="B34-nutrients-10-01561" ref-type="bibr">34</xref>].</p><p>DHA can be further converted into potent novel compounds with anti-inflammatory and organ-protective properties such as the specialized pro-resolving lipid mediators (SPMs), including D- and E-series resolvins, neuroprotectins, and maresins (<xref ref-type="fig" rid="nutrients-10-01561-f002">Figure 2</xref>) [<xref rid="B35-nutrients-10-01561" ref-type="bibr">35</xref>,<xref rid="B36-nutrients-10-01561" ref-type="bibr">36</xref>,<xref rid="B37-nutrients-10-01561" ref-type="bibr">37</xref>]. The ability of ALA to be converted into omega-3 long-chain PUFAs may be an important mechanism for maintain adequate EPA and DHA concentrations in cell membranes and thus optimal functioning of the tissues.</p><p>Burdge et al., designed a study to estimate the capacity of &#x003b1;-linolenic acid to be converted into omega-3 long-chain polyunsaturated fatty acids [<xref rid="B38-nutrients-10-01561" ref-type="bibr">38</xref>]. Carbon isotope labelling was used and 13C-ALA was administered orally to six young male subjects who consumed it as part of their usual diet. The results obtained suggested that the liver was the principal site of ALA desaturation and elongation, but the analysis also indicated that approximately 8% of dietary ALA is converted to EPA. There was no significant 13C enrichment of DHA above natural abundance at any of the time points measured over 21 days, thus the percentage of ALA converted to DHA was estimated to be 0&#x02013;4% [<xref rid="B38-nutrients-10-01561" ref-type="bibr">38</xref>]. Another study based on radioisotope-labelled ALA application suggested that its conversion to long-chain metabolites is approximately 6% for EPA and 3.8% for DHA in the case of a diet high in saturated fat. However, with a diet rich in n-6 PUFA, this conversion can be reduced by 40&#x02013;50% [<xref rid="B39-nutrients-10-01561" ref-type="bibr">39</xref>]. Comparative data have been provided in an analysis conducted by Talahalli et al., on the uptake, tissue deposition, and conversion of ALA to its long-chain metabolites EPA and DHA, compared to EPA + DHA intake [<xref rid="B40-nutrients-10-01561" ref-type="bibr">40</xref>]. The level of EPA and DHA was measured in rat&#x02019;s liver, heart, brain, and serum after 60 days of dietary intake of linseed oil, fish oil, and groundnut oil. The obtained results indicated that to maintain a given level of EPA and DHA, required amount of dietary ALA is a few times higher than the combined amount of EPA + DHA (fish oil). Therefore, the efficacy of ALA is lower when compared to applied EPA + DHA in elevating serum and tissue long-chain n-3 PUFA levels [<xref rid="B40-nutrients-10-01561" ref-type="bibr">40</xref>].</p><p>In the omega-6 family, LA is converted to &#x003b3;-linolenic acid (GLA, 18:3, n-6) due to the activity of &#x00394;6-desaturase enzyme, and then GLA is elongated to form dihomo-GLA (DGLA, 20:3, n-6), which is the precursor of the first series of prostaglandins (PGs). Through &#x00394;5-desaturase action, GLA can also be converted to arachidonic acid (AA), which forms the precursor of the second series of prostaglandins and thromboxanes and the fourth series of leukotrienes.</p><p>It is known that the activities of desaturases and elongases involved in the metabolism of EFAs are affected by a number of factors, many of which contribute to reducing the activity of enzymes responsible for ALA and EPA conversion (e.g., smoking, alcohol, stress (adrenaline), deficiencies of certain vitamins or minerals) [<xref rid="B41-nutrients-10-01561" ref-type="bibr">41</xref>]. &#x00394;6-desaturase activity is inhibited by oncogenic viruses and radiation, while the activity of &#x00394;6 desaturase has been proven to reduce with age [<xref rid="B42-nutrients-10-01561" ref-type="bibr">42</xref>]. However, in recent years various publications have reported on compounds that could stimulate PUFAs conversion. Co-factors essential for normal &#x02206;6-desaturase activity include pyridoxine, zinc, and magnesium. &#x00394;6-desaturase is activated by insulin, whereas diabetics have reduced &#x00394;6-desaturase activity [<xref rid="B43-nutrients-10-01561" ref-type="bibr">43</xref>]. On the transcriptional level, peroxisome proliferator-activated receptor-&#x003b1; (PPAR-&#x003b1;) activator WY-14.643 significantly enhanced the transcription of hepatic &#x00394;6-desaturase by more than 500% [<xref rid="B44-nutrients-10-01561" ref-type="bibr">44</xref>].</p><p>Another study based on mice fed with diets containing either a 1.5% fatty acid preparation rich in conjugated linoleic acid (CLA) or rich in LA revealed that dietary CLA concurrently increases the activity and mRNA levels of enzymes involved in fatty acid synthesis and oxidation, as well as PUFAs desaturation in the mouse liver, which appears to be mediated by both the activation of PPAR-&#x003b1; and upregulation of SREBP-1 (sterol regulatory element binding protein-1) [<xref rid="B45-nutrients-10-01561" ref-type="bibr">45</xref>]. </p><p>Omega-3s and omega-6s present various antagonistic activities. Arachidonic acid undergoes transformation to eicosanoids (leukotrienes, thromboxanes, and the precursor of the first series of prostaglandins), activating the inflammatory and prothrombotic processes, thus facilitating platelet aggregation. AA and EPA also are transformed into their respective hydroxy acids, which in turn are converted into leukotrienes (LTs). Prostaglandins and leukotrienes are highly biologically active, are characterized by pro-inflammatory activity, and are known to be involved in various pathological processes, such as atherosclerosis, bronchial asthma, inflammatory bowel disease, and several other inflammatory conditions.</p><p>Hence, most omega-6 fatty acids tend to promote inflammation, whereas the omega-3 fatty acids group has been evidenced to help reduce inflammation. It is worth emphasizing again that some of the most potent inhibitors of desaturases are omega-6 fatty acids, which are present in the modern diet at about 20-fold higher levels than the omega-3s. Nowadays, in addition to saturated fats and trans fatty acid isomers, omega-6s are the most common fat compounds in our modern Western diet, which is rich in vegetable oils, margarine, and deep fried fast food. It has been found that the amount and type of dietary fats in the daily diet and their improper proportions can be involved in the risk of lifestyle diseases, such as obesity, cardiovascular diseases, and cancer, as well as immune system weakening [<xref rid="B46-nutrients-10-01561" ref-type="bibr">46</xref>,<xref rid="B47-nutrients-10-01561" ref-type="bibr">47</xref>].</p></sec><sec id="sec2dot3-nutrients-10-01561"><title>2.3. CVD Risk Factors</title><p>In its Global Atlas on Cardiovascular Disease Prevention and Control, the World Health Organization (WHO) divided cardiovascular risk factors into modifiable and non-modifiable ones [<xref rid="B48-nutrients-10-01561" ref-type="bibr">48</xref>]. It reported that most cardiovascular diseases are triggered by risk factors that can be controlled, treated, or modified, such as high blood pressure, lipid disorders, overweight/obesity, tobacco use, lack of physical activity, and diabetes. The WHO together with World Health Federation (WHF) have been raising concerns that in 2008, 9.8% of men and 13.8% of women were obese (with a body mass index (BMI) higher than or equal to 30 kg/m<sup>2</sup>), compared to 4.8% for men and 7.9% for women in 1980. In regard to tobacco users, the WHO estimates that there are currently about 1 billion smokers in the world today. A higher risk of CVDs development was associated with heavy smokers, female smokers and young male smokers [<xref rid="B49-nutrients-10-01561" ref-type="bibr">49</xref>]. It was emphasized in the report that cardiovascular risk increases with elevated blood glucose values and therefore CVDs account for about 60% of all mortality in people with diabetes.</p><p>However, in addition to the variable risk factors, there are also some major CVD factors that cannot be controlled, which include age, gender, and genetic predisposition based on family history. It is well-known that CVDs become increasingly common with age. As a person gets older, the heart undergoes subtle physiologic changes, even in the absence of disease. As the heart muscle undergoes ageing it is often unable to relax completely between beats, and as a result, the pumping chambers become stiffer and may work less efficiently. With respect to the age factor, some studies suggest that men are at greater risk of heart disease than pre-menopausal women. Once past menopause, a woman&#x02019;s risk is comparable to that of a man. However, the answer for whether premenopausal women are protected from atherosclerotic disease by virtue of their hormonal status still remains inconclusive. The same risk factors for cardiovascular diseases appear to act in women as in men, although the general insufficiency of women presented in a large number of studies means that far less information about the importance of these risk factors is available to us. In light of these data, the risk of stroke is similar for men and women [<xref rid="B50-nutrients-10-01561" ref-type="bibr">50</xref>,<xref rid="B51-nutrients-10-01561" ref-type="bibr">51</xref>].</p></sec><sec id="sec2dot4-nutrients-10-01561"><title>2.4. Modern Diet as a Precursor for Inflammation Progression</title><p>A healthy diet is a major factor reducing the risk of heart disease. The WHF has reported that comparisons between a diet low in saturated fats, with plenty of fresh fruit and vegetables, and the typical diet of someone living in the developed world show that the former can result in a 73% reduction in the risk of major cardiac events [<xref rid="B48-nutrients-10-01561" ref-type="bibr">48</xref>]. Awareness regarding the importance of diet in the development and prevention of cardiovascular disease needs to be raised.</p><p>A population study has shown that the foods typically consumed in Western diets are heavily laden with fatty acids of the omega-6 family. The current human diet has nothing to do with the diet of our ancestors, and it is generally accepted that hunter-gatherer societies, and other less &#x0201c;Westernized&#x0201d; populations, exhibited superior health markers, such as body composition and physical fitness, when compared to Western populations. Throughout 4&#x02013;5 million years of hominid evolution, diets were abundant in omega-3 fatty acids from fish and raw meat, but relatively low in omega-6 seed oils. Simopoulos quotes several sources informing that human beings evolved on a diet with a specific proportion of omega-6 to omega-3 fatty acids of approximately 1, whereas nowadays this ratio in Western diets is 15/1&#x02013;16.7/1 [<xref rid="B26-nutrients-10-01561" ref-type="bibr">26</xref>,<xref rid="B52-nutrients-10-01561" ref-type="bibr">52</xref>].</p><p>Sources of omega-6 fats include the common vegetable oils used in cooking (corn, safflower, sunflower, etc.), hydrogenated versions of these oils used to make margarine and vegetable shortening, and animal origin food derived from livestock raised on grain, rather than on green pasture. The volume of omega-6 sources in the average diet largely exceeds the volume of omega-3 fatty acids sources&#x02014;green vegetables, wild ocean fish, flaxseed, walnuts, and animals raised on green vegetation. As a result, Americans usually have omega-6 to omega-3 fatty acids ratios in their tissues on a level of 10:1 to 20:1. With this preponderance of omega-6s in the diet, there is no wonder why people suffer from the consequences of excess omega-6, which are manifested in chronic inflammation, hypertension, as well as an increased blood clotting tendency that elevates the risk for heart attack and stroke.</p></sec><sec id="sec2dot5-nutrients-10-01561"><title>2.5. Lipid Profile</title><p>Monitoring and maintaining healthy levels of lipids circulating in our blood stream is important in prevention and early diagnosis of cardiovascular diseases. A lipid profile or lipid panel is a group of blood tests used to evaluate the risk of developing cardiovascular problems or to control an applied treatment.</p><p>A lipid profile typically includes total cholesterol, high-density lipoprotein (HDL) cholesterol (the cholesterol in HDL particles), low-density lipoprotein (LDL) cholesterol (the cholesterol combined in LDL particles), and triglycerides (TGs).</p><p>HDL cholesterol is considered to be &#x0201c;good&#x0201d; cholesterol, since it helps to remove excess cholesterol from the arteries. HDL particles act as cleaners, carrying LDL cholesterol back to the liver, where it is decomposed and removed from the body. Changes in lipid profile have been associated with cardiovascular diseases due to their key role in the maintenance of the integrity of the cell membrane.</p><p>A single LDL particle formed from apolipoproteins B (apoB) is about 220&#x02013;275 angstroms in diameter, and typically transports 3000 to 6000 fat molecules including cholesterol, phospholipids, and triglycerides (with the amounts of each varying considerably) [<xref rid="B53-nutrients-10-01561" ref-type="bibr">53</xref>]. Therefore, LDL, the so-called &#x0201c;bad&#x0201d; cholesterol, deposits an excess of cholesterol in the walls of blood vessels, which can contribute to atherosclerosis, ischemic heart disease, or, in some cases, to heart attack. As a quite simple measurement, a lipid profile can provide important information about the progression of diseases.</p><p>Since the majority of animal studies were conducted with species that can readily convert ALA to EPA and DHA, it is not easy to isolate the advantages of ALA per se, although there is evidence of ALA affecting vascular function and heart condition [<xref rid="B54-nutrients-10-01561" ref-type="bibr">54</xref>]. It has been found that dietary flaxseed significantly improves lipid profiles in hyperlipidemic patients and may positively affect cardiovascular risk factors modification [<xref rid="B54-nutrients-10-01561" ref-type="bibr">54</xref>]. Subsequently, Egert et al., conducted a randomized strictly controlled dietary study to compare the individual effects of dietary ALA, EPA, and DHA on low-density lipoprotein (LDL) and fatty acid composition [<xref rid="B55-nutrients-10-01561" ref-type="bibr">55</xref>]. Their findings demonstrated how ALA benefited lipoprotein profiles, but in contrast, EPA and DHA led to oxidized LDL formation [<xref rid="B55-nutrients-10-01561" ref-type="bibr">55</xref>]. Consistent with these results, another study investigated the differential effects of omega-3 PUFAs on metabolic control and vascular reactivity and documented pointed benefits of ALA [<xref rid="B56-nutrients-10-01561" ref-type="bibr">56</xref>,<xref rid="B57-nutrients-10-01561" ref-type="bibr">57</xref>]. Goyens et al., evaluated the effects of ALA in comparison to EPA and DHA in a nutritional intervention study [<xref rid="B58-nutrients-10-01561" ref-type="bibr">58</xref>]. According to their conclusions, in healthy elderly subjects, ALA might affect the levels of LDL-cholesterol and apoB more favorably than EPA/DHA, with the intake level of ALA being of critical importance [<xref rid="B58-nutrients-10-01561" ref-type="bibr">58</xref>,<xref rid="B59-nutrients-10-01561" ref-type="bibr">59</xref>].</p><p>It is worth mentioning that lipid profile disorders also include abnormalities in triglycerides (TGs) levels in blood plasma. Combined dyslipidemia concerns concurrent unbeneficial changes in various subfractions of lipids, including increased levels of LDL cholesterol and TGs and a reduced level of HDL cholesterol. It was demonstrated in numerous studies that statins, especially at higher doses, are able to reduce blood TGs level, however, it was proved that omega-3 fatty acids are more effective in this case [<xref rid="B60-nutrients-10-01561" ref-type="bibr">60</xref>]. The recent meta-analysis prepared by Alexander et al. [<xref rid="B61-nutrients-10-01561" ref-type="bibr">61</xref>] mentioned a prominent effect of omega-3 long-chain PUFAs supplementation in lowering the concentration of serum TGs, and emphasized that an elevated TGslevel is responsible for an increased CVD risk. Thus, the combination therapy of statins and omega-3s may be useful when there is need for the optimization of TGs levels in the event of combined dyslipidemia [<xref rid="B62-nutrients-10-01561" ref-type="bibr">62</xref>]. It was demonstrated in the study by Weber and Raederstorff [<xref rid="B60-nutrients-10-01561" ref-type="bibr">60</xref>] that omega-3 fatty acids supplementation may reduce serum TG levels by 20% to 40%, and the authors suggest that this is due to lowered production of very low-density lipoprotein (VLDLs) or an enhanced clearance of chylomicron TGs [<xref rid="B63-nutrients-10-01561" ref-type="bibr">63</xref>]. It was demonstrated in the study by Davidson et al. [<xref rid="B64-nutrients-10-01561" ref-type="bibr">64</xref>] that the combined administration of statin (simvastatin&#x02014;40 mg/d) and omega-3 supplement (465 mg EPA and 375 mg DHA per 1-g capsule) positively affected the blood plasma lipid profile (a decrease in non-HDL-C, VLDL-C, and TG), and this effect was more profound than in the case of statin or omega-3s alone [<xref rid="B64-nutrients-10-01561" ref-type="bibr">64</xref>]. Also, Micallef and Garg [<xref rid="B65-nutrients-10-01561" ref-type="bibr">65</xref>] concluded in their study that the potential benefits related to blood lipid parameters such as cholesterol and TGs level can be enhanced using omega-3s as an adjunct to statin therapy.</p></sec><sec id="sec2dot6-nutrients-10-01561"><title>2.6. Atherosclerosis</title><p>Healthy arteries are flexible and elastic, but over time, the arteries&#x02019; walls can harden and the lumen of blood vessels can become narrower. The direct cause of atherosclerosis is plaque accumulating and building up inside the arteries. Plaque is a miscellany of cholesterol, cells, and debris that creates a bump on the artery wall. It all begins with damage to the endothelium&#x02014;a thin layer of cells lining the interior surface of blood vessels&#x02014;that can be caused by risk factors such as high blood pressure, smoking, or high cholesterol, that afterwards leads to plaque formation.</p><p>Although atherosclerosis is often considered a heart problem, it can affect any artery in the body, including arteries in the heart, brain, arms, legs, pelvis, and kidneys. As a result, different diseases may develop based on which arteries are affected. </p><p>In the last decades, epidemiological, clinical, and experimental studies have demonstrated that a diet rich in omega-3 plays a central role in atherosclerosis prevention [<xref rid="B66-nutrients-10-01561" ref-type="bibr">66</xref>,<xref rid="B67-nutrients-10-01561" ref-type="bibr">67</xref>,<xref rid="B68-nutrients-10-01561" ref-type="bibr">68</xref>].</p><p>Results of various research studies have shown that the suppression of atherosclerosis is associated with reduced levels of serum lipids and antioxidant activity. A recent study hat was designed to evaluate the effects of flaxseed oil containing &#x003b1;-linolenic acid ester of plant sterols (ALA-PS) demonstrated that ALA-PS flaxseed oil synergistically interacted in atherosclerosis ameliorating as well as in optimizing overall lipid levels, contracting inflammation, and lowering oxidative stress [<xref rid="B69-nutrients-10-01561" ref-type="bibr">69</xref>]. Another animal study suggested that ingestion of oxidized flaxseed oil increases hepatic plasma malondialdehyde (MDA) concentration and is potentially pro-atherogenic. Mice from the control group received fresh flaxseed oil, while the experimental population received the same diet with heated flaxseed oil. The results obtained demonstrated that aortic wall thickness increased and lumen and diameter parameters changed only in the experimental group [<xref rid="B70-nutrients-10-01561" ref-type="bibr">70</xref>]. Effects of flaxseed on serum lipids in experimental animals have been variable&#x02014;from no change to spotted reduction. In the study conducted by Prasad, 14 g ALA per day was reported as a threshold dose [<xref rid="B71-nutrients-10-01561" ref-type="bibr">71</xref>]. The lower dose did not affect inflammatory mediators, but 14 g/d or higher limited and reduced inflammatory markers. The same study also demonstrated that flaxseed can suppress hypercholesterolemic atherosclerosis in a rabbit model.</p></sec><sec id="sec2dot7-nutrients-10-01561"><title>2.7. Cardioprotective Effects via Antithrombotic Activity</title><p>Solid experimental evidence of different effects of omega-3 fatty acids on individual components of cardiovascular risk has been described. Multiple research studies revealed that omega-3 long-chain fatty acids may prevent myocardial infarction and arrhythmia, decrease systolic, and diastolic blood pressure and improve vascular function. This effect can be explained by very rapid omega-3 fatty acids incorporation into cell membranes, thus affecting the function of cells and tissues with subsequent impacts on the production of various vasoactive eicosanoids and other mediators [<xref rid="B72-nutrients-10-01561" ref-type="bibr">72</xref>]. Although the exact mechanisms of the beneficial effect of omega-3s on cardiovascular diseases are multifactorial and remain unclear, a series of omega-3 PUFAs action has been proven and described as mechanisms with major importance for cardiology.</p><p>Both anticoagulant and antiplatelet functions of omega-3 PUFAs were explored in the past with inconsistent findings, therefore complementary studies were required [<xref rid="B73-nutrients-10-01561" ref-type="bibr">73</xref>,<xref rid="B74-nutrients-10-01561" ref-type="bibr">74</xref>]. Antiplatelet and antithrombotic activity of omega-3 PUFAs has been documented in patients with coronary artery disease (CAD) in an experimental study where PUFAs were distributed independently or in a combined treatment [<xref rid="B75-nutrients-10-01561" ref-type="bibr">75</xref>,<xref rid="B76-nutrients-10-01561" ref-type="bibr">76</xref>,<xref rid="B77-nutrients-10-01561" ref-type="bibr">77</xref>] (e.g., with aspirin and clopidogrel [<xref rid="B78-nutrients-10-01561" ref-type="bibr">78</xref>,<xref rid="B79-nutrients-10-01561" ref-type="bibr">79</xref>]). The results obtained may be of significant clinical importance, as they indicated the ability to improve platelet response to clopidogrel by omega-3 PUFA co-administration in coronary artery disease patients treated with angioplasty (percutaneous coronary intervention) who are carriers of the loss-of-function CYP2C19 genetic variant. These findings are also supported by the results of the TRITON-TIMI 38 study subanalysis [<xref rid="B80-nutrients-10-01561" ref-type="bibr">80</xref>].</p><p>Antithrombotic potential was also confirmed in a study based on dietary administration of oil-rich fish (500 g/week for 4 weeks), which resulted in reduced platelet-monocyte aggregation in the study group compared to the control [<xref rid="B81-nutrients-10-01561" ref-type="bibr">81</xref>]. Additionally, when administered concomitantly with policosanol (10 mg/d)&#x02014;a mixture of higher aliphatic primary alcohols purified from sugar-cane wax&#x02014;oil-rich fish were shown to be a safe and effective as a lipid-lowering agent [<xref rid="B82-nutrients-10-01561" ref-type="bibr">82</xref>,<xref rid="B83-nutrients-10-01561" ref-type="bibr">83</xref>,<xref rid="B84-nutrients-10-01561" ref-type="bibr">84</xref>].</p><p>A recent study by Mozaffarian and Wu reviewing available evidence for cardiovascular effects of n-3 polyunsaturated fatty acid provides a compelling indication regarding the beneficial effects of omega 3 fatty acids in reducing the risk of cardiac death [<xref rid="B85-nutrients-10-01561" ref-type="bibr">85</xref>]. Experimental studies confirmed that omega-3 fatty acids may improve cardiac function due to their anticoagulant, anti-triglyceridemic, antihypertensive, hemostatic, and antiarrhythmic properties [<xref rid="B46-nutrients-10-01561" ref-type="bibr">46</xref>,<xref rid="B86-nutrients-10-01561" ref-type="bibr">86</xref>,<xref rid="B87-nutrients-10-01561" ref-type="bibr">87</xref>,<xref rid="B88-nutrients-10-01561" ref-type="bibr">88</xref>,<xref rid="B89-nutrients-10-01561" ref-type="bibr">89</xref>].</p></sec><sec id="sec2dot8-nutrients-10-01561"><title>2.8. Antiarrhythmic Properties</title><p>Antiarrhythmic properties are of particular interest to researchers. The antiarrhythmic effect of omega-3 fatty acids has been widely described and explained by their effect on the ionic currents and sodium channels in the plasma membrane of cardiomyocytes [<xref rid="B90-nutrients-10-01561" ref-type="bibr">90</xref>,<xref rid="B91-nutrients-10-01561" ref-type="bibr">91</xref>,<xref rid="B92-nutrients-10-01561" ref-type="bibr">92</xref>]. The results of previous studies show that free PUFAs can reduce the membrane electrical excitability of heart cells. Impact on sodium channels causes a shift in the state of dynamic balance inactivation towards hyperpolarized potentials. Consequently, the cardiomyocytes are less susceptible to stimulation. Furthermore, it appears that omega-3 PUFAs are characterized by even higher efficacy in arrhythmia conditions triggered by fresh ischemia (this situation often results in ventricular fibrillation). It was also confirmed in a study involving an animal model. A concentrate of free fish-oil fatty acids in oral administration was tested with respect to its prevention effect on sudden cardiac death in dogs, and the obtained results indicate that purified omega-3 fatty acids could prevent ischemia-induced ventricular fibrillation in the applied dog model [<xref rid="B93-nutrients-10-01561" ref-type="bibr">93</xref>].</p><p>Regarding the suggestion that the cardioprotective effect of fish intake is mainly due to the antiarrhythmic properties of marine n-3 polyunsaturated fatty acids, which modulate ion currents, omega-3 PUFAs of vegetable origin were also examined. Epidemiological studies and dietary trials in humans suggest that &#x003b1;-linolenic acid is a major cardioprotective nutrient [<xref rid="B94-nutrients-10-01561" ref-type="bibr">94</xref>,<xref rid="B95-nutrients-10-01561" ref-type="bibr">95</xref>]. The effects of ALA on the specific Kv1.5 channel have also been examined. The results of the studies conducted by Dhein et al. or Guizy et al. indicated that ALA directly blocks atria-specific Kv1.5 channels without modifying their expression or the bilayer order. Together with the indicated influence of EPA and DHA, these effects suggest that the antiarrhythmic potential of diets enriched with plant-derived n-3 PUFAs may partially result from direct effects on cardiac ion channels [<xref rid="B96-nutrients-10-01561" ref-type="bibr">96</xref>,<xref rid="B97-nutrients-10-01561" ref-type="bibr">97</xref>].</p></sec><sec id="sec2dot9-nutrients-10-01561"><title>2.9. Myocardial Infarction</title><p>Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack, occurs due to damage to the heart muscle caused by stopped blood flow, which prevents blood from reaching the heart&#x02014;this refers to STEMI (ST-elevated myocardial infarction) or injured heart muscle caused by major obstruction in blood flow through coronary arteries (NSTEMI&#x02014;non-ST-elevated myocardial infarction). The MI mechanism often involves the complete blockage of a coronary artery caused by a rupture of an atherosclerotic plaque. Low density lipoprotein (LDL) can contain 70% total plasma cholesterol and&#x02014;as mentioned previously&#x02014;is considered the foremost malefactor triggering inflammatory processes and early plaque formation, which later might lead to MI and stroke. It was identified by Assmann and Gotto that reduction in the LDL levels could lower the incidence of coronary heart disease (CHD), including MI, by up to one-third. HDL (the good lipoprotein, which carries only 20% total plasma cholesterol) has also been linked to the rates of coronary events in epidemiological and clinical studies [<xref rid="B98-nutrients-10-01561" ref-type="bibr">98</xref>]. Although LDL is the lipoprotein most commonly associated with atherosclerosis and cardiovascular risk, other lipoproteins, such as VLDL (very low-density lipoprotein), might also act as atherogenic factors. On the other hand, HDL appears to play a protective role, and high levels of HDL particles are associated with a lower risk of coronary artery disease. The cardioprotective effects of HDL have been attributed to its role in reverse cholesterol transport [<xref rid="B99-nutrients-10-01561" ref-type="bibr">99</xref>,<xref rid="B100-nutrients-10-01561" ref-type="bibr">100</xref>]. The results of a clinical study on non-insulin-dependent diabetic individuals consuming a diversified ratio of dietary polyunsaturated to saturated fatty acid (P/S) indicated that fish oil significantly reduced plasma triacylglycerol levels (<italic>p</italic> &#x0003c; 0.05) and increased EPA and DHA content of all lipoprotein lipid classes. Demonty et al., concluded that a modest intake of omega-3 fatty acids, such as could be obtained due to regular fish consumption, would reduce plasma triglyceride levels without affecting LDL or HDL cholesterol levels [<xref rid="B101-nutrients-10-01561" ref-type="bibr">101</xref>]. It is worth mentioning that an increasing amount of data indicate that to initiate atherosclerosis, LDL has to undergo chemical modification, such as oxidation or glycation, since these particles are more liable to retention within the vessel wall intima [<xref rid="B102-nutrients-10-01561" ref-type="bibr">102</xref>]. Modified or damaged LDLs or their particular types (e.g., VLDL) have become a subject of interest in regard to their role in CVDs. Thus, when it comes to cholesterol particles, a high LDL level by itself cannot be considered to be the decisive factor responsible for cardiovascular dysfunctions. Current evidence suggests that cardiovascular risk depends on the &#x0201c;quality&#x0201d; rather than only the &#x0201c;quantity&#x0201d; of LDL [<xref rid="B103-nutrients-10-01561" ref-type="bibr">103</xref>,<xref rid="B104-nutrients-10-01561" ref-type="bibr">104</xref>].</p><p>The Lyon Diet Heart Study found plasma ALA to be associated with an improved prognosis for recurrent myocardial infarction, but it did not find a similar association with long-chain omega-3 fatty acids. A meta-analysis of five prospective studies on ALA suggested that high ALA intake was associated with reduced risk of fatal heart disease (relative risk 0.79, 0.60&#x02013;1.04) [<xref rid="B105-nutrients-10-01561" ref-type="bibr">105</xref>]. The average highest level of intake was 2 g per day versus the lowest of 0.8 g per day [<xref rid="B105-nutrients-10-01561" ref-type="bibr">105</xref>]. Omega-3 fatty acids may provide rapid protective effects in patients with AMI, according to the results of a randomized, placebo-controlled long-term trial. The effects of treatment with fish oil (eicosapentaenoic acid, 1.08 g/day) and mustard oil (&#x003b1;-linolenic acid, 2.9 g/day) were compared for 1 year in the management of patients divided into a fish oil group, a mustard oil group, and placebo patients with suspected AMI. The fish oil and mustard oil groups showed a significant reduction in total cardiac arrhythmias, left ventricular enlargement, and angina pectoris compared to the placebo group [<xref rid="B106-nutrients-10-01561" ref-type="bibr">106</xref>]. Sun et al., have recently presented how plasmatic long-chain omega-3 PUFAs levels are associated with a lower risk of AMI in Asian population [<xref rid="B107-nutrients-10-01561" ref-type="bibr">107</xref>]. The case-control study results did not indicate conclusive findings. According to the authors, plasma ALA may be slightly associated with reduced AMI risk, even in individuals with high concentrations of long-chain omega-3s, and this may be partially mediated by lower blood pressure and LDL cholesterol level [<xref rid="B107-nutrients-10-01561" ref-type="bibr">107</xref>]. Contrary to the pointed importance of the aforementioned finding, the results of the study by Derbali et al., proved that flaxseed oil has a significant effect in heart protection against isoproterenol-induced myocardial infarction. Linum oil pre-co-treatment was reported as an agent preventing almost all induced MI parameters through the beneficial effect of the important ALA fraction [<xref rid="B108-nutrients-10-01561" ref-type="bibr">108</xref>].</p></sec><sec id="sec2dot10-nutrients-10-01561"><title>2.10. Atrial Fibrillation</title><p>An abnormal heart rhythm characterized by irregular, commonly rapid beating, which affects about 2 to 3 per cent of the population in Europe and North America, is another common concomitant disease with coronary artery disease, myocardial infarction, and cardiomyopathy. This condition, i.e., atrial fibrillation (AF), has become one of the most important public health problems over the last 20 years, and is a significant cause of increasing health care costs in Western countries [<xref rid="B109-nutrients-10-01561" ref-type="bibr">109</xref>].</p><p>An epidemiologic approach has been applied in order to evaluate the relationship between plasma ALA levels, dietary ALA consumption, and AF risk. Fretts et al.&#x02019;s research group investigated subjects who were 65 years or older at study entry and detected no relationship between plasma ALA and AF incident after correcting for age, sex, and a variety of clinical and demographic factors [<xref rid="B110-nutrients-10-01561" ref-type="bibr">110</xref>]. However, a technical weaknesses of the study included plasma ALA levels measurement only occurring at a single time point [<xref rid="B110-nutrients-10-01561" ref-type="bibr">110</xref>,<xref rid="B111-nutrients-10-01561" ref-type="bibr">111</xref>]. It should be mentioned that a similar epidemiologic study has recently reported a beneficial effect of dietary ALA with respect to heart failure risk. Atrial fibrillation and heart failure are frequently comorbid conditions. It seems probable that diets that substantially increase ALA consumption with concurrent decrease in omega-6 PUFAs intake would beneficially affect cardiovascular morbidity and mortality [<xref rid="B112-nutrients-10-01561" ref-type="bibr">112</xref>]. Calo et al., conducted an open-label, prospective, randomized study in order to assess the efficacy of preoperative and postoperative treatment with omega-3 PUFAs in preventing the occurrence of AF, which is the most coincident complication associated with coronary artery bypass graft surgery [<xref rid="B113-nutrients-10-01561" ref-type="bibr">113</xref>]. The daily doses of omega-3 PUFAs consisted of two gelatin capsules containing 850 to 882 mg EPA and DHA as ethyl esters with an average ratio of 1:2 EPA/DHA. As a result, postoperative AF was noted in 15.2% (12 of 79) of the patients in the PUFA group compared to 33.3% (27 of 81) of those in the control group. Additionally, the PUFA patients were hospitalized after surgery for significantly fewer days than the controls. This was the first study to demonstrate that individuals supplemented with omega-3 PUFAs presented a decreased risk ratio in cardiac events, like the incidence of postoperative atrial fibrillation [<xref rid="B113-nutrients-10-01561" ref-type="bibr">113</xref>,<xref rid="B114-nutrients-10-01561" ref-type="bibr">114</xref>]. ALA&#x02019;s role either in isoproterenol-treated isolated rat cardiomyocytes or in in vivo rat hearts was studied, and it was demonstrated that an ALA-enriched diet protects the heart against induced fibrosis and hypertrophy [<xref rid="B115-nutrients-10-01561" ref-type="bibr">115</xref>].</p></sec><sec id="sec2dot11-nutrients-10-01561"><title>2.11. Stroke</title><p>Ischemic stroke is considered to be one of the more important reasons of death and prolonged disability among the adults [<xref rid="B116-nutrients-10-01561" ref-type="bibr">116</xref>,<xref rid="B117-nutrients-10-01561" ref-type="bibr">117</xref>,<xref rid="B118-nutrients-10-01561" ref-type="bibr">118</xref>]. Commonly applied and approved stroke therapy involves the use of tissue plasminogen activator (tPA), which, however, is substantially limited by a short temporal window of application [<xref rid="B119-nutrients-10-01561" ref-type="bibr">119</xref>]. Thus, an important issue in stroke-related research is the search for some alternative therapies that would be safe in the case of long-term prophylactic administration. Although numerous studies have demonstrated that the brain of an adult is able to try to repair itself in reaction to ischemic insults, no safe, efficient therapies that would enhance repair mechanisms and thus prevent neurological deficits induced by stroke have been recognized. Therefore, attention has been paid to neurorestorative therapies that are able to boost cerebral brain repair and concurrently enhance post-ischemia neurological recovery [<xref rid="B120-nutrients-10-01561" ref-type="bibr">120</xref>,<xref rid="B121-nutrients-10-01561" ref-type="bibr">121</xref>,<xref rid="B122-nutrients-10-01561" ref-type="bibr">122</xref>].</p><p>Many studies on stroke models have shown that omega-3 fatty acids are able to protect against ischemic brain injury [<xref rid="B123-nutrients-10-01561" ref-type="bibr">123</xref>,<xref rid="B124-nutrients-10-01561" ref-type="bibr">124</xref>,<xref rid="B125-nutrients-10-01561" ref-type="bibr">125</xref>], but the mechanisms of these actions have not been fully explained. It was suggested that this inability to explain the underlying mechanisms behind the protective effect of omega-3 fatty acids could be due to the multiple effects of these acids, i.e., anti-inflammatory activity [<xref rid="B125-nutrients-10-01561" ref-type="bibr">125</xref>,<xref rid="B126-nutrients-10-01561" ref-type="bibr">126</xref>], oxidative stress reduction [<xref rid="B127-nutrients-10-01561" ref-type="bibr">127</xref>], heme oxygenase induction [<xref rid="B128-nutrients-10-01561" ref-type="bibr">128</xref>], or neurogenesis and oligodendrogenesis potentiation [<xref rid="B124-nutrients-10-01561" ref-type="bibr">124</xref>]. Palmer et al. [<xref rid="B129-nutrients-10-01561" ref-type="bibr">129</xref>] also suggested that omega-3s are also able to promote the formation of new blood vessels.</p><p>A study conducted by Wang et al. [<xref rid="B116-nutrients-10-01561" ref-type="bibr">116</xref>] demonstrated that an endogenous post-stroke angiogenesis was induced by omega-3 supplementation, and this measure may be considered to be a potential angiogenic factor enhancing endogenous tissue repair and improving long-term functional recovery after stroke. In turn, Zhang et al. [<xref rid="B130-nutrients-10-01561" ref-type="bibr">130</xref>] demonstrated in their study that prolonged administration of fish oil caused an increase in cerebral omega-3 level and provided long-term histological and neurological protection against ischemic brain damage. This study also demonstrated that omega-3 PUFAs derived from dietary supplementation can actively promote brain repair due to the possibility of post-stroke brain revascularization as well as enhanced neurogenesis and oligodendrogenesis, not only alleviate ischemic brain injury. </p><p>The study conducted by Mozaffarian et al. [<xref rid="B131-nutrients-10-01561" ref-type="bibr">131</xref>] revealed that total omega-3 level in plasma was inversely correlated with ischemic stroke risk; however, the authors did not demonstrate any significant effect in the case of hemorrhagic stroke [<xref rid="B131-nutrients-10-01561" ref-type="bibr">131</xref>]. A meta-analysis of fish consumption relation to stroke conducted by Larsson and Orsini [<xref rid="B132-nutrients-10-01561" ref-type="bibr">132</xref>] demonstrated that increased fish consumption (three servings per week) was associated with a 6% lower stroke incidence [<xref rid="B132-nutrients-10-01561" ref-type="bibr">132</xref>]. Also, a meta-analysis of cohort studies performed by He et al. [<xref rid="B133-nutrients-10-01561" ref-type="bibr">133</xref>] showed an inverse relationship between stroke (especially ischemic one) and fish consumption. However, in another study [<xref rid="B134-nutrients-10-01561" ref-type="bibr">134</xref>], fish oil supplementation was not related to a decreased stroke incidence. Also, a meta-analysis conducted by Siscovick et al. [<xref rid="B135-nutrients-10-01561" ref-type="bibr">135</xref>] provided only minor evidence of stroke incidence decrease in patients supplemented with omega-3 PUFAs. Similar conclusions were reported by other meta-analyses [<xref rid="B136-nutrients-10-01561" ref-type="bibr">136</xref>,<xref rid="B137-nutrients-10-01561" ref-type="bibr">137</xref>,<xref rid="B138-nutrients-10-01561" ref-type="bibr">138</xref>].</p><p>It can thus be concluded based on the aforementioned evidence that fish consumption is more efficient in stroke prevention compared to omega-3 supplements [<xref rid="B139-nutrients-10-01561" ref-type="bibr">139</xref>]. Also, a 12-year follow-up study in men demonstrated a 45% lower risk of ischemic stroke, but no change in hemorrhagic stroke incidence, in the case of fish consumption (2&#x02013;4 servings/week) [<xref rid="B140-nutrients-10-01561" ref-type="bibr">140</xref>]. Despite the beneficial effects related to fish consumption and stroke incidence reduction demonstrated above, some other studies did not provide such strong evidence [<xref rid="B141-nutrients-10-01561" ref-type="bibr">141</xref>,<xref rid="B142-nutrients-10-01561" ref-type="bibr">142</xref>]. The discrepancies observed in different studies conducted on various populations may be due to different patterns and kinds of fish consumed as well as their preparation manners [<xref rid="B142-nutrients-10-01561" ref-type="bibr">142</xref>,<xref rid="B143-nutrients-10-01561" ref-type="bibr">143</xref>,<xref rid="B144-nutrients-10-01561" ref-type="bibr">144</xref>].</p></sec></sec><sec id="sec3-nutrients-10-01561"><title>3. Safety Concerns</title><p>Despite abundant evidence on the beneficial activity of omega-3 fatty acids on human health, including cardiovascular diseases, there are also some concerns regarding the safety of their administration. The main concern is related to the possibility of an increased bleeding risk as a result of omega-3s supplementation. According to Bays [<xref rid="B145-nutrients-10-01561" ref-type="bibr">145</xref>], the involvement of omega-3s in eicosanoid metabolism may be the biochemical cause of possible increased bleeding in the case of increased omega-3 fatty intake. The author points out, that although there is little evidence for an increased risk for clinically significant bleeding incidence with omega-3 fatty acid supplementation, this should be taken into account.</p><p>It was suggested that the antithrombotic effect of omega-3s can partially increase the bleeding risk, or even a sudden cardiac death. It was suggested, moreover, that fish oil therapy can cause a slightly higher risk of hemorrhagic stroke, but clinical evidence has not related an increased bleeding with omega-3 fatty acid consumption, even in combination with other agents that potentially increase bleeding (e.g., aspirin) [<xref rid="B146-nutrients-10-01561" ref-type="bibr">146</xref>]. This was confirmed in the study conducted by Watson et al. [<xref rid="B147-nutrients-10-01561" ref-type="bibr">147</xref>].</p><p>A study concerning the relationship between omega-3 fatty acid index and bleeding in the course of AMI was conducted by Salisbury et al. [<xref rid="B148-nutrients-10-01561" ref-type="bibr">148</xref>]. The authors suggested that, despite numerous benefits related to CVDs, omega-3 acids can also inhibit platelet aggregation, thus increasing the risk of bleeding. However, following a study on a large, multicenter group of AMI patients, the authors concluded that there is no relationship between the bleeding and omega-3 index, and thus the concerns about bleeding should not prevent the use of omega-3 supplementation in the case of clinical indications.</p><p>Another concern related to the safety of omega-3s is the high instability of fish oil and its susceptibility to oxidation, which may contribute to intolerance by patients and an increased risk of toxicity [<xref rid="B145-nutrients-10-01561" ref-type="bibr">145</xref>,<xref rid="B149-nutrients-10-01561" ref-type="bibr">149</xref>,<xref rid="B150-nutrients-10-01561" ref-type="bibr">150</xref>]. Finally, fish consumption may also be related to the risk of poisoning with environmental toxins like mercury, polychlorinated biphenyls, dioxins, or hypervitaminosis due to consumption of fish oils containing high levels of fat-soluble vitamins D and A [<xref rid="B145-nutrients-10-01561" ref-type="bibr">145</xref>,<xref rid="B151-nutrients-10-01561" ref-type="bibr">151</xref>,<xref rid="B152-nutrients-10-01561" ref-type="bibr">152</xref>]. However, these risks can be reduced substantially via purification processes used during fish oil supplements and medical preparations production or supplementation with plant origin omega-3s [<xref rid="B145-nutrients-10-01561" ref-type="bibr">145</xref>].</p></sec><sec id="sec4-nutrients-10-01561"><title>4. Perspectives</title><p>Omega-3 fatty acids have been shown in epidemiological and clinical trials to reduce the incidence of CVD. The daily intake of fish or plant origin oil rich in omega-3 fatty acid corresponding to recommended dosage may prove to be difficult, albeit valuable. Thus, an alternative method of supplementation may be oral omega n3-PUFA therapy, which represents a potentially huge factor of interest and motivation for the pharmaceutical industry. Pharmaceutical and biomedical companies are increasingly interested in the subject of omega-3 fatty acids and their metabolites, and subsequently there has been a substantial amount of research on supplements of omega-3s, particularly those found in seafood and fish oil, and heart disease. Omega-3 fatty acid supplements usually do not have negative side effects. When side effects do occur, they typically consist of minor gastrointestinal symptoms, such as belching, indigestion, or diarrhea. Although the biggest group of omega-3 supplements is based on marine or fish oils, vegetable oils have become increasingly popular and approachable in this matter, not only for vegans and vegetarians but also for people concerned about having a healthy balanced diet. Commonly used alternative dietary supplements based on &#x003b1;-linolenic acid include flaxseed oil and algae oils as a source of DHA. Plant oils (source of ALA) serving as an omega-3 supplements are as potent and effective as fish based oils (containing mainly EPA and DHA fatty acids). However, ALA with only three double bonds is not as susceptible to oxidation as EPA (five bonds) and DHA (six bonds). A substantial part of fish oils is oxidized during the production process, which significantly reduces the pharmacological activity and may confer toxic properties.</p></sec><sec id="sec5-nutrients-10-01561"><title>5. Conclusions</title><p>Exogenous polyunsaturated fatty acids deserve special attention, given the importance of their physiological functions, determined by the limited capacity of fatty acid desaturation by human tissues. As is clear from the above facts, omega-3 fatty acids, particularly alpha-linolenic acid (the pharmacologically active precursor of EPA and DHA), have a broad spectrum of anti-inflammatory and cardio-protective activities. There is, however, still need for further research into the function of ALA as an independent nutrient. In conclusion, the beneficial effects of omega-3 fatty acids and their esters have been previously documented in terms of both primary and secondary prevention of cardiovascular system disorders. It has to be highlighted, however, that the achievement of optimal performance requires an appropriate quantitative composition and the proper proportions of delivered fatty acids. A healthy balanced diet, especially when combined with regular physical activity and smart supplementation of omega-3 fatty acids, has been reported as being effective in preventing cardiovascular events, cardiac death, and coronary events, especially in persons with high cardiovascular risk. </p></sec></body><back><ack><title>Acknowledgments</title><p>Publication supported by Wroc&#x00142;aw Centre of Biotechnology, programme the Leading National Research Centre (KNOW) for years 2014&#x02013;2018.</p></ack><notes><title>Author Contributions</title><p>E.S.-W. and T.W. conceived and designed the manuscript; K.C., R.B., and T.W. collected the data; J.W., E.S.W., and K.C. wrote the manuscript; J.W., R.B., B.P.-S., and S.L. revised drafts of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of interest</title><p>The authors declare that there is no conflict of interest regarding the publication of this paper.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">AA</td><td align="left" valign="middle" rowspan="1" colspan="1">arachidonic acid (20:4, n-6)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AF</td><td align="left" valign="middle" rowspan="1" colspan="1">atrial fibrillation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ALA</td><td align="left" valign="middle" rowspan="1" colspan="1">alpha-/&#x003b1;-linolenic acid (18:3, n-3)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AMI</td><td align="left" valign="middle" rowspan="1" colspan="1">acute myocardial infarction</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CAD</td><td align="left" valign="middle" rowspan="1" colspan="1">coronary artery disease</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CVD</td><td align="left" valign="middle" rowspan="1" colspan="1">cardiovascular disease</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DHA</td><td align="left" valign="middle" rowspan="1" colspan="1">docosahexaenoic acid (22:6, n-3)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EFA</td><td align="left" valign="middle" rowspan="1" colspan="1">essential fatty acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EPA</td><td align="left" valign="middle" rowspan="1" colspan="1">eicosapentaenoic acid (20:5, n-3)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GLA</td><td align="left" valign="middle" rowspan="1" colspan="1">gamma-/&#x003b3;-linolenic acid (18:3, n-6)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HDL</td><td align="left" valign="middle" rowspan="1" colspan="1">high-density lipoprotein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IHD</td><td align="left" valign="middle" rowspan="1" colspan="1">ischemic heart disease</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LA</td><td align="left" valign="middle" rowspan="1" colspan="1">linoleic acid (18:2, n-6)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LDL</td><td align="left" valign="middle" rowspan="1" colspan="1">low-density lipoprotein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MI</td><td align="left" valign="middle" rowspan="1" colspan="1">myocardial infarction</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MUFA</td><td align="left" valign="middle" rowspan="1" colspan="1">monounsaturated fatty acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PUFA</td><td align="left" valign="middle" rowspan="1" colspan="1">polyunsaturated fatty acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TGs</td><td align="left" valign="middle" rowspan="1" colspan="1">triglycerides</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VLDL</td><td align="left" valign="middle" rowspan="1" colspan="1">very low-density lipoprotein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">WHF</td><td align="left" valign="middle" rowspan="1" colspan="1">World Health Federation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">WHO</td><td align="left" valign="middle" rowspan="1" colspan="1">World Health Organization</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-nutrients-10-01561"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodkowski</surname><given-names>R.</given-names></name><name><surname>Patkowska-Sokola</surname><given-names>B.</given-names></name><name><surname>Filip-Psurska</surname><given-names>B.</given-names></name><name><surname>Kempinska</surname><given-names>K.</given-names></name><name><surname>Wietrzyk</surname><given-names>J.</given-names></name><name><surname>Czyz</surname><given-names>K.</given-names></name><name><surname>Walisiewicz-Niedbalska</surname><given-names>W.</given-names></name><name><surname>Usydus</surname><given-names>Z.</given-names></name></person-group><article-title>Evaluation of the anti-proliferative activity of natural lipid preparations against tumor cell lines</article-title><source>J. Anim. Vet. Adv.</source><year>2014</year><volume>13</volume><fpage>257</fpage><lpage>266</lpage></element-citation></ref><ref id="B2-nutrients-10-01561"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabian</surname><given-names>C.J.</given-names></name><name><surname>Kimler</surname><given-names>B.F.</given-names></name><name><surname>Hursting</surname><given-names>S.D.</given-names></name></person-group><article-title>Omega-3 fatty acids for breast cancer prevention and survivorship</article-title><source>Breast Cancer Res.</source><year>2015</year><volume>17</volume><fpage>62</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1186/s13058-015-0571-6</pub-id><?supplied-pmid 25936773?><pub-id pub-id-type="pmid">25936773</pub-id></element-citation></ref><ref id="B3-nutrients-10-01561"><label>3.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>S.</given-names></name><name><surname>Ralston</surname><given-names>J.</given-names></name><name><surname>Taubert</surname><given-names>K.</given-names></name></person-group><source>Urbanization and Cardiovascular Disease: Raising Heart-Healthy Children in Today&#x02019;s Cities</source><publisher-name>The World Heart Federation</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2012</year></element-citation></ref><ref id="B4-nutrients-10-01561"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>S.S.</given-names></name><name><surname>Vos</surname><given-names>T.</given-names></name><name><surname>Flaxman</surname><given-names>A.D.</given-names></name></person-group><article-title>A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990&#x02013;2010: A systematic analysis for the Global Burden of Disease Study 2010</article-title><source>Lancet</source><year>2012</year><volume>380</volume><fpage>2224</fpage><lpage>2260</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)61766-8</pub-id><pub-id pub-id-type="pmid">23245609</pub-id></element-citation></ref><ref id="B5-nutrients-10-01561"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tvermosegaard</surname><given-names>M.</given-names></name><name><surname>Dahl-Petersen</surname><given-names>I.K.</given-names></name><name><surname>Nielsen</surname><given-names>N.O.</given-names></name><name><surname>Bjerregaard</surname><given-names>P.</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>M.E.</given-names></name></person-group><article-title>Cardiovascular Disease Susceptibility and Resistance in Circumpolar Inuit Populations</article-title><source>Can. J. Cardiol.</source><year>2015</year><volume>31</volume><fpage>1116</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1016/j.cjca.2015.06.002</pub-id><?supplied-pmid 26239003?><pub-id pub-id-type="pmid">26239003</pub-id></element-citation></ref><ref id="B6-nutrients-10-01561"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000f8;rgensen</surname><given-names>M.E.</given-names></name><name><surname>Moustgaard</surname><given-names>H.</given-names></name><name><surname>Bjerregaard</surname><given-names>P.</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K.</given-names></name></person-group><article-title>Gender differences in the association between westernization and metabolic risk among Greenland Inuit</article-title><source>Eur. J. Epidemiol.</source><year>2006</year><volume>21</volume><fpage>741</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1007/s10654-006-9063-4</pub-id><?supplied-pmid 17077992?><pub-id pub-id-type="pmid">17077992</pub-id></element-citation></ref><ref id="B7-nutrients-10-01561"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fodor</surname><given-names>J.G.</given-names></name><name><surname>Helis</surname><given-names>E.</given-names></name><name><surname>Yazdekhasti</surname><given-names>N.</given-names></name><name><surname>Vohnout</surname><given-names>B.</given-names></name></person-group><article-title>&#x0201c;Eskimos and heart disease&#x0201d; story: Facts or wishful thinking?</article-title><source>Can. J. Cardiol.</source><year>2014</year><volume>30</volume><fpage>864</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.1016/j.cjca.2014.04.007</pub-id><?supplied-pmid 25064579?><pub-id pub-id-type="pmid">25064579</pub-id></element-citation></ref><ref id="B8-nutrients-10-01561"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchioli</surname><given-names>R.</given-names></name><name><surname>Schweiger</surname><given-names>C.</given-names></name><name><surname>Tavazzi</surname><given-names>L.</given-names></name><name><surname>Valagussa</surname><given-names>F.</given-names></name></person-group><article-title>Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: Results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell&#x02019;Infarto Miocardico</article-title><source>Lipids</source><year>2001</year><volume>36</volume><issue>Suppl. 1</issue><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1007/s11745-001-0694-8</pub-id></element-citation></ref><ref id="B9-nutrients-10-01561"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchioli</surname><given-names>R.</given-names></name><name><surname>Barzi</surname><given-names>F.</given-names></name><name><surname>Bomba</surname><given-names>E.</given-names></name><name><surname>Chieffo</surname><given-names>C.</given-names></name><name><surname>Di Gregorio</surname><given-names>D.</given-names></name><name><surname>Di Mascio</surname><given-names>R.</given-names></name><name><surname>Franzosi</surname><given-names>M.G.</given-names></name><name><surname>Geraci</surname><given-names>E.</given-names></name><name><surname>Levantesi</surname><given-names>G.</given-names></name><name><surname>Maggioni</surname><given-names>A.P.</given-names></name><etal/></person-group><article-title>Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell&#x02019;Infarto Miocardico (GISSI)-Prevenzione</article-title><source>Circulation</source><year>2002</year><volume>105</volume><fpage>1897</fpage><lpage>1903</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000014682.14181.F2</pub-id><?supplied-pmid 11997274?><pub-id pub-id-type="pmid">11997274</pub-id></element-citation></ref><ref id="B10-nutrients-10-01561"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalal</surname><given-names>J.J.</given-names></name><name><surname>Kasliwal</surname><given-names>R.R.</given-names></name><name><surname>Dutta</surname><given-names>A.L.</given-names></name><name><surname>Sawhney</surname><given-names>J.P.S.</given-names></name><name><surname>Iyengar</surname><given-names>S.S.</given-names></name><name><surname>Dani</surname><given-names>S.</given-names></name><name><surname>Desai</surname><given-names>N.</given-names></name><name><surname>Sathyamurthy</surname><given-names>I.</given-names></name><name><surname>Rao</surname><given-names>D.</given-names></name><name><surname>Menon</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Role of omega-3 ethyl ester concentrate in reducing sudden cardiac death following myocardial infarction and in management of hypertriglyceridemia: An Indian consensus statement</article-title><source>Indian Heart J.</source><year>2012</year><volume>64</volume><fpage>503</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1016/j.ihj.2012.08.004</pub-id><?supplied-pmid 23102390?><pub-id pub-id-type="pmid">23102390</pub-id></element-citation></ref><ref id="B11-nutrients-10-01561"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchioli</surname><given-names>R.</given-names></name><name><surname>Levantesi</surname><given-names>G.</given-names></name></person-group><article-title>N-3 PUFAs and heart failure</article-title><source>Int. J. Cardiol.</source><year>2013</year><volume>170</volume><issue>Suppl. 1</issue><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2013.06.041</pub-id><?supplied-pmid 24012159?><pub-id pub-id-type="pmid">24012159</pub-id></element-citation></ref><ref id="B12-nutrients-10-01561"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patkowska-Soko&#x00142;a</surname><given-names>B.</given-names></name><name><surname>Usydus</surname><given-names>Z.</given-names></name><name><surname>Szlinder-Richert</surname><given-names>J.</given-names></name><name><surname>Bodkowski</surname><given-names>R.</given-names></name></person-group><article-title>Technology for recovering omega-3 fatty acids from family from fish oils and protecting them against oxidative changes</article-title><source>Przem. Chem.</source><year>2009</year><volume>88</volume><fpage>548</fpage><lpage>552</lpage></element-citation></ref><ref id="B13-nutrients-10-01561"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodkowski</surname><given-names>R.</given-names></name><name><surname>Szlinder-Richert</surname><given-names>J.</given-names></name><name><surname>Usydus</surname><given-names>Z.</given-names></name><name><surname>Patkowska-Soko&#x00142;a</surname><given-names>B.</given-names></name></person-group><article-title>An attempt of optimization of fish oil crystallization at low temperature</article-title><source>Przem. Chem.</source><year>2011</year><volume>90</volume><fpage>703</fpage><lpage>706</lpage></element-citation></ref><ref id="B14-nutrients-10-01561"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasbalg</surname><given-names>T.L.</given-names></name><name><surname>Hibbeln</surname><given-names>J.R.</given-names></name><name><surname>Ramsden</surname><given-names>C.R.</given-names></name><name><surname>Majchrzak</surname><given-names>S.F.</given-names></name><name><surname>Rawlings</surname><given-names>R.R.</given-names></name></person-group><article-title>Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century</article-title><source>Am. J. Clin. Nutr.</source><year>2011</year><volume>93</volume><fpage>950</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.3945/ajcn.110.006643</pub-id><?supplied-pmid 21367944?><pub-id pub-id-type="pmid">21367944</pub-id></element-citation></ref><ref id="B15-nutrients-10-01561"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>J.H.</given-names></name><name><surname>Lavie</surname><given-names>C.J.</given-names></name><name><surname>Harris</surname><given-names>W.S.</given-names></name></person-group><article-title>Omega-3 fatty acids: Cardiovascular benefits, sources and sustainability</article-title><source>Nat. Rev. Cardiol.</source><year>2009</year><volume>6</volume><fpage>753</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2009.188</pub-id><?supplied-pmid 19859067?><pub-id pub-id-type="pmid">19859067</pub-id></element-citation></ref><ref id="B16-nutrients-10-01561"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walisiewicz-Niedbalska</surname><given-names>W.</given-names></name><name><surname>Patkowska-Soko&#x00142;a</surname><given-names>B.</given-names></name><name><surname>Gwardiak</surname><given-names>H.</given-names></name><name><surname>Szulc</surname><given-names>T.</given-names></name><name><surname>Bodkowski</surname><given-names>R.</given-names></name><name><surname>R&#x000f3;&#x0017c;ycki</surname><given-names>K.</given-names></name></person-group><article-title>Potential raw materials in synthesis of bioactive fat derivatives</article-title><source>Przem. Chem.</source><year>2012</year><volume>91</volume><fpage>1058</fpage><lpage>1063</lpage></element-citation></ref><ref id="B17-nutrients-10-01561"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodkowski</surname><given-names>R.</given-names></name><name><surname>Czy&#x0017c;</surname><given-names>K.</given-names></name><name><surname>Kupczy&#x00144;ski</surname><given-names>R.</given-names></name><name><surname>Patkowska-Soko&#x00142;a</surname><given-names>B.</given-names></name><name><surname>Nowakowski</surname><given-names>P.</given-names></name><name><surname>Wiliczkiewicz</surname><given-names>A.</given-names></name></person-group><article-title>Lipid complex effect on fatty acid profile and chemical composition of cow milk and cheese</article-title><source>J. Dairy Sci.</source><year>2016</year><volume>99</volume><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.3168/jds.2015-9321</pub-id><?supplied-pmid 26506539?><pub-id pub-id-type="pmid">26506539</pub-id></element-citation></ref><ref id="B18-nutrients-10-01561"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soko&#x00142;a-Wysocza&#x00144;ska</surname><given-names>E.</given-names></name><name><surname>Wysocza&#x00144;ski</surname><given-names>T.</given-names></name><name><surname>Czy&#x0017c;</surname><given-names>K.</given-names></name><name><surname>Vogt</surname><given-names>A.</given-names></name><name><surname>Patkowska-Soko&#x00142;a</surname><given-names>B.</given-names></name><name><surname>Soko&#x00142;a</surname><given-names>K.</given-names></name><name><surname>Bodkowski</surname><given-names>R.</given-names></name><name><surname>Wyrostek</surname><given-names>A.</given-names></name><name><surname>Roman</surname><given-names>K.</given-names></name></person-group><article-title>Characteristics of polyunsaturated fatty acids ethyl esters with high alpha-linolenic acid content as a component of biologically active health-promoting supplements</article-title><source>Przem. Chem.</source><year>2014</year><volume>93</volume><fpage>1923</fpage><lpage>1927</lpage></element-citation></ref><ref id="B19-nutrients-10-01561"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usydus</surname><given-names>Z.</given-names></name><name><surname>Bodkowski</surname><given-names>R.</given-names></name><name><surname>Szlinder-Richert</surname><given-names>J.</given-names></name><name><surname>Patkowska-Soko&#x00142;a</surname><given-names>B.</given-names></name><name><surname>Dobrza&#x00144;ski</surname><given-names>Z.</given-names></name></person-group><article-title>Use of aminopropyl column extraction for fish oil enrichment in omega-3 acids</article-title><source>Przem. Chem.</source><year>2012</year><volume>91</volume><fpage>1043</fpage><lpage>1048</lpage></element-citation></ref><ref id="B20-nutrients-10-01561"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahmawaty</surname><given-names>S.</given-names></name><name><surname>Charlton</surname><given-names>K.</given-names></name><name><surname>Lyons-Wall</surname><given-names>P.</given-names></name><name><surname>Meyer</surname><given-names>B.J.</given-names></name></person-group><article-title>Dietary intake and food sources of EPA, DPA and DHA in Australian children</article-title><source>Lipids</source><year>2013</year><volume>48</volume><fpage>869</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1007/s11745-013-3812-4</pub-id><?supplied-pmid 23881381?><pub-id pub-id-type="pmid">23881381</pub-id></element-citation></ref><ref id="B21-nutrients-10-01561"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>B.J.</given-names></name><name><surname>Neil</surname><given-names>J.</given-names></name><name><surname>Mann</surname><given-names>N.J.</given-names></name><name><surname>Lewis</surname><given-names>J.L.</given-names></name><name><surname>Milligan</surname><given-names>G.C.</given-names></name><name><surname>Sinclair</surname><given-names>A.J.</given-names></name><name><surname>Howe</surname><given-names>P.R.C.</given-names></name></person-group><article-title>Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids</article-title><source>Lipids</source><year>2003</year><volume>38</volume><fpage>391</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1007/s11745-003-1074-0</pub-id><?supplied-pmid 12848284?><pub-id pub-id-type="pmid">12848284</pub-id></element-citation></ref><ref id="B22-nutrients-10-01561"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnoldussen</surname><given-names>I.A.</given-names></name><name><surname>Kiliaan</surname><given-names>A.J.</given-names></name></person-group><article-title>Impact of DHA on metabolic diseases from womb to tomb</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>6190</fpage><lpage>6212</lpage><pub-id pub-id-type="doi">10.3390/md12126190</pub-id><?supplied-pmid 25528960?><pub-id pub-id-type="pmid">25528960</pub-id></element-citation></ref><ref id="B23-nutrients-10-01561"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finch</surname><given-names>J.</given-names></name><name><surname>Munhutu</surname><given-names>M.N.</given-names></name><name><surname>Whitaker-Worth</surname><given-names>D.L.</given-names></name></person-group><article-title>Atopic dermatitis and nutrition</article-title><source>Clin. Dermatol.</source><year>2010</year><volume>28</volume><fpage>605</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1016/j.clindermatol.2010.03.032</pub-id><?supplied-pmid 21034985?><pub-id pub-id-type="pmid">21034985</pub-id></element-citation></ref><ref id="B24-nutrients-10-01561"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>D.T.</given-names></name><name><surname>Deuster</surname><given-names>P.A.</given-names></name><name><surname>Harris</surname><given-names>W.S.</given-names></name><name><surname>MacRae</surname><given-names>H.</given-names></name><name><surname>Dretsch</surname><given-names>M.N.</given-names></name></person-group><article-title>Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. Servicemembers</article-title><source>Nutr. Neurosci.</source><year>2013</year><volume>16</volume><fpage>30</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1179/1476830512Y.0000000025</pub-id><?supplied-pmid 22748167?><pub-id pub-id-type="pmid">22748167</pub-id></element-citation></ref><ref id="B25-nutrients-10-01561"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-de-Lorenzo</surname><given-names>A.</given-names></name><name><surname>Denia</surname><given-names>R.</given-names></name><name><surname>Atlan</surname><given-names>P.</given-names></name><name><surname>Martinez-Ratero</surname><given-names>S.</given-names></name><name><surname>Le Brun</surname><given-names>A.</given-names></name><name><surname>Evard</surname><given-names>D.</given-names></name><name><surname>Bereziat</surname><given-names>G.</given-names></name></person-group><article-title>Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: A randomised double-blind study of an olive oil-based lipid emulsion v. medium/long-chain triacylglycerols</article-title><source>Br. J. Nutr.</source><year>2005</year><volume>94</volume><fpage>221</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1079/BJN20051467</pub-id><?supplied-pmid 16115356?><pub-id pub-id-type="pmid">16115356</pub-id></element-citation></ref><ref id="B26-nutrients-10-01561"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simopoulos</surname><given-names>A.P.</given-names></name></person-group><article-title>An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity</article-title><source>Nutrients</source><year>2016</year><volume>8</volume><elocation-id>128</elocation-id><pub-id pub-id-type="doi">10.3390/nu8030128</pub-id><?supplied-pmid 26950145?><pub-id pub-id-type="pmid">26950145</pub-id></element-citation></ref><ref id="B27-nutrients-10-01561"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedorova</surname><given-names>I.</given-names></name><name><surname>Hussein</surname><given-names>N.</given-names></name><name><surname>Baumann</surname><given-names>M.H.</given-names></name><name><surname>Di Martino</surname><given-names>C.</given-names></name><name><surname>Salem</surname><given-names>N.</given-names></name></person-group><article-title>An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze</article-title><source>Behav. Neurosci.</source><year>2009</year><volume>123</volume><fpage>196</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1037/a0013801</pub-id><?supplied-pmid 19170444?><pub-id pub-id-type="pmid">19170444</pub-id></element-citation></ref><ref id="B28-nutrients-10-01561"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallebage-Gamarallage</surname><given-names>M.M.</given-names></name><name><surname>Lam</surname><given-names>V.</given-names></name><name><surname>Takechi</surname><given-names>R.</given-names></name><name><surname>Galloway</surname><given-names>S.</given-names></name><name><surname>Mamo</surname><given-names>J.C.L.</given-names></name></person-group><article-title>A diet enriched in docosahexanoic acid exacerbates brain parenchymal extravasation of apo B lipoproteins induced by chronic ingestion of saturated fats</article-title><source>Int. J. Vasc. Med.</source><year>2012</year><volume>647689</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1155/2012/647689</pub-id><?supplied-pmid 22121489?><pub-id pub-id-type="pmid">22121489</pub-id></element-citation></ref><ref id="B29-nutrients-10-01561"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haast</surname><given-names>R.A.</given-names></name><name><surname>Kiliaan</surname><given-names>A.J.</given-names></name></person-group><article-title>Impact of fatty acids on brain circulation, structure and function</article-title><source>Prostaglandins Leukot. Essent. Fatty Acids</source><year>2015</year><volume>92</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.plefa.2014.01.002</pub-id><?supplied-pmid 24485516?><pub-id pub-id-type="pmid">24485516</pub-id></element-citation></ref><ref id="B30-nutrients-10-01561"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wysocza&#x00144;ski</surname><given-names>T.</given-names></name><name><surname>Soko&#x00142;a-Wysocza&#x00144;ska</surname><given-names>E.</given-names></name><name><surname>P&#x00119;kala</surname><given-names>J.</given-names></name><name><surname>Lochy&#x00144;ski</surname><given-names>St.</given-names></name><name><surname>Czy&#x0017c;</surname><given-names>K.</given-names></name><name><surname>Bodkowski</surname><given-names>R.</given-names></name><name><surname>Herbinger</surname><given-names>G.</given-names></name><name><surname>Patkowska-Soko&#x00142;a</surname><given-names>B.</given-names></name><name><surname>Librowski</surname><given-names>T.</given-names></name></person-group><article-title>Omega-3 fatty acids and their role in central nervous system&#x02014;A Review</article-title><source>Curr. Med. Chem.</source><year>2016</year><volume>23</volume><fpage>816</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.2174/0929867323666160122114439</pub-id><?supplied-pmid 26795198?><pub-id pub-id-type="pmid">26795198</pub-id></element-citation></ref><ref id="B31-nutrients-10-01561"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>M.H.</given-names></name></person-group><article-title>Omega-3 fatty acids: New insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid</article-title><source>Curr. Opin. Lipidol.</source><year>2013</year><volume>24</volume><fpage>467</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1097/MOL.0000000000000019</pub-id><?supplied-pmid 24184945?><pub-id pub-id-type="pmid">24184945</pub-id></element-citation></ref><ref id="B32-nutrients-10-01561"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>M.T.</given-names></name><name><surname>Nara</surname><given-names>T.Y.</given-names></name></person-group><article-title>Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases</article-title><source>Annu. Rev. Nutr.</source><year>2004</year><volume>24</volume><fpage>345</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1146/annurev.nutr.24.121803.063211</pub-id><?supplied-pmid 15189125?><pub-id pub-id-type="pmid">15189125</pub-id></element-citation></ref><ref id="B33-nutrients-10-01561"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.J.</given-names></name><name><surname>Green</surname><given-names>P.</given-names></name><name><surname>Mann</surname><given-names>J.J.</given-names></name><name><surname>Rapoport</surname><given-names>S.I.</given-names></name><name><surname>Sublette</surname><given-names>M.E.</given-names></name></person-group><article-title>Pathways of polyunsaturated fatty acid utilization: Implications for brain function in neuropsychiatric health and disease</article-title><source>Brain Res.</source><year>2015</year><volume>1597</volume><fpage>220</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2014.11.059</pub-id><?supplied-pmid 25498862?><pub-id pub-id-type="pmid">25498862</pub-id></element-citation></ref><ref id="B34-nutrients-10-01561"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demar</surname><given-names>J.C.</given-names></name><name><surname>Ma</surname><given-names>K.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name><name><surname>Bell</surname><given-names>J.M.</given-names></name><name><surname>Rapoport</surname><given-names>S.I.</given-names></name></person-group><article-title>Alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid</article-title><source>J. Neurochem.</source><year>2005</year><volume>94</volume><fpage>1063</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03258.x</pub-id><?supplied-pmid 16092947?><pub-id pub-id-type="pmid">16092947</pub-id></element-citation></ref><ref id="B35-nutrients-10-01561"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serhan</surname><given-names>C.N.</given-names></name></person-group><article-title>Pro-resolving lipid mediators are leads for resolution physiology</article-title><source>Nature</source><year>2014</year><volume>510</volume><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1038/nature13479</pub-id><?supplied-pmid 24899309?><pub-id pub-id-type="pmid">24899309</pub-id></element-citation></ref><ref id="B36-nutrients-10-01561"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serhan</surname><given-names>C.N.</given-names></name><name><surname>Yang</surname><given-names>R.</given-names></name><name><surname>Martinod</surname><given-names>K.</given-names></name><name><surname>Kasuga</surname><given-names>K.</given-names></name><name><surname>Pillai</surname><given-names>P.S.</given-names></name><name><surname>Porter</surname><given-names>T.F.</given-names></name><name><surname>Oh</surname><given-names>S.F.</given-names></name><name><surname>Spite</surname><given-names>M.</given-names></name></person-group><article-title>Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions</article-title><source>J. Exp. Med.</source><year>2009</year><volume>206</volume><fpage>15</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1084/jem.20081880</pub-id><?supplied-pmid 19103881?><pub-id pub-id-type="pmid">19103881</pub-id></element-citation></ref><ref id="B37-nutrients-10-01561"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinohara</surname><given-names>M.</given-names></name><name><surname>Mirakaj</surname><given-names>V.</given-names></name><name><surname>Serhan</surname><given-names>C.N.</given-names></name></person-group><article-title>Functional metabolomics reveals novel active products in the DHA metabolome</article-title><source>Front Immunol.</source><year>2012</year><pub-id pub-id-type="doi">10.3389/fimmu.2012.00081</pub-id><?supplied-pmid 22566962?><pub-id pub-id-type="pmid">22566962</pub-id></element-citation></ref><ref id="B38-nutrients-10-01561"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burdge</surname><given-names>G.C.</given-names></name><name><surname>Jones</surname><given-names>A.E.</given-names></name><name><surname>Wootton</surname><given-names>S.A.</given-names></name></person-group><article-title>Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men</article-title><source>Br. J. Nutr.</source><year>2002</year><volume>88</volume><fpage>355</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1079/BJN2002662</pub-id><?supplied-pmid 12323085?><pub-id pub-id-type="pmid">12323085</pub-id></element-citation></ref><ref id="B39-nutrients-10-01561"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abedi</surname><given-names>E.</given-names></name><name><surname>Sahari</surname><given-names>M.A.</given-names></name></person-group><article-title>Long-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional properties</article-title><source>Food Sci. Nutr.</source><year>2014</year><volume>2</volume><fpage>443</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1002/fsn3.121</pub-id><?supplied-pmid 25473503?><pub-id pub-id-type="pmid">25473503</pub-id></element-citation></ref><ref id="B40-nutrients-10-01561"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talahalli</surname><given-names>R.R.</given-names></name><name><surname>Vallikannan</surname><given-names>B.</given-names></name><name><surname>Sambaiah</surname><given-names>K.</given-names></name><name><surname>Lokesh</surname><given-names>B.R.</given-names></name></person-group><article-title>Lower efficacy in the utilization of dietary ALA as compared to preformed EPA + DHA on long chain n-3 PUFA levels in rats</article-title><source>Lipids</source><year>2010</year><volume>45</volume><fpage>799</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1007/s11745-010-3464-6</pub-id><?supplied-pmid 20734237?><pub-id pub-id-type="pmid">20734237</pub-id></element-citation></ref><ref id="B41-nutrients-10-01561"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D.</given-names></name><name><surname>Pischon</surname><given-names>T.</given-names></name><name><surname>Hankinson</surname><given-names>S.E.</given-names></name><name><surname>Rifai</surname><given-names>N.</given-names></name><name><surname>Joshipura</surname><given-names>K.</given-names></name><name><surname>Willett</surname><given-names>W.C.</given-names></name><name><surname>Rimm</surname><given-names>E.B.</given-names></name></person-group><article-title>Dietary intake of trans fatty acids and systemic inflammation in women</article-title><source>Am. J. Clin. Nutr.</source><year>2004</year><volume>79</volume><fpage>606</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1093/ajcn/79.4.606</pub-id><?supplied-pmid 15051604?><pub-id pub-id-type="pmid">15051604</pub-id></element-citation></ref><ref id="B42-nutrients-10-01561"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghezzi</surname><given-names>S.</given-names></name><name><surname>Rise</surname><given-names>P.</given-names></name><name><surname>Ceruti</surname><given-names>S.</given-names></name><name><surname>Galli</surname><given-names>C.</given-names></name></person-group><article-title>Effects of cigarette smoke on cell viability, linoleic acid metabolism and cholesterol synthesis, in THP-1 cells</article-title><source>Lipids</source><year>2007</year><volume>42</volume><fpage>629</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1007/s11745-007-3070-4</pub-id><?supplied-pmid 17551762?><pub-id pub-id-type="pmid">17551762</pub-id></element-citation></ref><ref id="B43-nutrients-10-01561"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>U.N.</given-names></name></person-group><article-title>Essential fatty acids: Biochemistry, physiology and pathology</article-title><source>Biotechnol. J.</source><year>2006</year><volume>1</volume><fpage>420</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1002/biot.200600012</pub-id><?supplied-pmid 16892270?><pub-id pub-id-type="pmid">16892270</pub-id></element-citation></ref><ref id="B44-nutrients-10-01561"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>C.</given-names></name><name><surname>Cho</surname><given-names>H.P.</given-names></name><name><surname>Nakamura</surname><given-names>M.T.</given-names></name><name><surname>Clarke</surname><given-names>S.D.</given-names></name></person-group><article-title>Regulation of human delta-6 desaturase gene transcription: Identification of a functional direct repeat-1 element</article-title><source>J. Lipid Res.</source><year>2003</year><volume>44</volume><fpage>686</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1194/jlr.M200195-JLR200</pub-id><?supplied-pmid 12562861?><pub-id pub-id-type="pmid">12562861</pub-id></element-citation></ref><ref id="B45-nutrients-10-01561"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>Y.</given-names></name><name><surname>Kushiro</surname><given-names>M.</given-names></name><name><surname>Shinohara</surname><given-names>K.</given-names></name><name><surname>Ide</surname><given-names>T.</given-names></name></person-group><article-title>Activity and mRNA levels of enzymes involved in hepatic fatty acid synthesis and oxidation in mice fed conjugated linoleic acid</article-title><source>Biochim. Biophys. Acta</source><year>2003</year><volume>1631</volume><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/S1388-1981(03)00038-6</pub-id><pub-id pub-id-type="pmid">12668178</pub-id></element-citation></ref><ref id="B46-nutrients-10-01561"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kromhout</surname><given-names>D.</given-names></name><name><surname>Yasuda</surname><given-names>S.</given-names></name><name><surname>Geleijnse</surname><given-names>J.M.</given-names></name><name><surname>Shimokawa</surname><given-names>H.</given-names></name></person-group><article-title>Fish oil and omega-3 fatty acids in cardiovascular disease: Do they really work?</article-title><source>Eur. Heart J.</source><year>2012</year><volume>33</volume><fpage>436</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehr362</pub-id><?supplied-pmid 21933782?><pub-id pub-id-type="pmid">21933782</pub-id></element-citation></ref><ref id="B47-nutrients-10-01561"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadzhieva</surname><given-names>B.</given-names></name><name><surname>Dimitrov</surname><given-names>M.</given-names></name><name><surname>Obreshkova</surname><given-names>D.</given-names></name><name><surname>Petkova</surname><given-names>V.</given-names></name><name><surname>Atanasov</surname><given-names>P.</given-names></name><name><surname>Kasnakova</surname><given-names>P.</given-names></name></person-group><article-title>Omega-3 polyunsaturated fatty acids metabolism and prevention of some socially significant diseases world</article-title><source>J. Pharm. Pharm. Sci.</source><year>2016</year><volume>5</volume><fpage>304</fpage><lpage>316</lpage></element-citation></ref><ref id="B48-nutrients-10-01561"><label>48.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mendis</surname><given-names>S.</given-names></name><name><surname>Puska</surname><given-names>P.</given-names></name><name><surname>Norrving</surname><given-names>B.</given-names></name></person-group><source>Global Atlas on Cardiovascular Disease Prevention and Control</source><publisher-name>WHO</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2011</year><fpage>164</fpage></element-citation></ref><ref id="B49-nutrients-10-01561"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teo</surname><given-names>K.K.</given-names></name><name><surname>Ounpuu</surname><given-names>S.</given-names></name><name><surname>Hawken</surname><given-names>S.</given-names></name><name><surname>Pandey</surname><given-names>M.R.</given-names></name><name><surname>Valentin</surname><given-names>V.</given-names></name><name><surname>Hunt</surname><given-names>D.</given-names></name><name><surname>Diaz</surname><given-names>R.</given-names></name><name><surname>Rashed</surname><given-names>W.</given-names></name><name><surname>Freeman</surname><given-names>R.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: A case-control study</article-title><source>Lancet</source><year>2006</year><volume>368</volume><fpage>647</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(06)69249-0</pub-id><pub-id pub-id-type="pmid">16920470</pub-id></element-citation></ref><ref id="B50-nutrients-10-01561"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiao</surname><given-names>Y.A.</given-names></name><name><surname>Rabinovitch</surname><given-names>P.S.</given-names></name></person-group><article-title>The aging heart</article-title><source>Cold Spring Harb. Perspect. Med.</source><year>2015</year><volume>5</volume><fpage>a025148</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a025148</pub-id><?supplied-pmid 26328932?><pub-id pub-id-type="pmid">26328932</pub-id></element-citation></ref><ref id="B51-nutrients-10-01561"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rota</surname><given-names>M.</given-names></name><name><surname>Goichberg</surname><given-names>P.</given-names></name><name><surname>Anversa</surname><given-names>P.</given-names></name><name><surname>Leri</surname><given-names>A.</given-names></name></person-group><article-title>Aging effects on cardiac progenitor cell physiology</article-title><source>Compr. Physiol.</source><year>2015</year><volume>5</volume><fpage>1705</fpage><lpage>1750</lpage><pub-id pub-id-type="pmid">26426465</pub-id></element-citation></ref><ref id="B52-nutrients-10-01561"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simopoulos</surname><given-names>A.P.</given-names></name></person-group><article-title>Evolutionary aspects of diet: The omega-6/omega-3 ratio and the brain</article-title><source>Mol. Neurobiol.</source><year>2011</year><volume>44</volume><fpage>203</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1007/s12035-010-8162-0</pub-id><?supplied-pmid 21279554?><pub-id pub-id-type="pmid">21279554</pub-id></element-citation></ref><ref id="B53-nutrients-10-01561"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundaram</surname><given-names>M.</given-names></name><name><surname>Yao</surname><given-names>Z.</given-names></name></person-group><article-title>Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion</article-title><source>Nutr. Metab.</source><year>2010</year><volume>7</volume><fpage>35</fpage><pub-id pub-id-type="doi">10.1186/1743-7075-7-35</pub-id><?supplied-pmid 20423497?><pub-id pub-id-type="pmid">20423497</pub-id></element-citation></ref><ref id="B54-nutrients-10-01561"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandasescu</surname><given-names>S.</given-names></name><name><surname>Mocanu</surname><given-names>V.</given-names></name><name><surname>Dascalita</surname><given-names>A.M.</given-names></name><name><surname>Haliga</surname><given-names>R.</given-names></name><name><surname>Nestian</surname><given-names>I.</given-names></name><name><surname>Stitt</surname><given-names>P.A.</given-names></name><name><surname>Luca</surname><given-names>V.</given-names></name></person-group><article-title>Flaxseed supplementation in hyperlipidemic patients</article-title><source>Rev. Med. Chir. Soc. Med. Nat. Iasi.</source><year>2005</year><volume>109</volume><fpage>502</fpage><lpage>506</lpage><?supplied-pmid 16607740?><pub-id pub-id-type="pmid">16607740</pub-id></element-citation></ref><ref id="B55-nutrients-10-01561"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egert</surname><given-names>S.</given-names></name><name><surname>Somoza</surname><given-names>V.</given-names></name><name><surname>Kannenberg</surname><given-names>F.</given-names></name><name><surname>Fobker</surname><given-names>M.</given-names></name><name><surname>Krome</surname><given-names>K.</given-names></name><name><surname>Erbersdobler</surname><given-names>H.F.</given-names></name><name><surname>Wahrburg</surname><given-names>U.</given-names></name></person-group><article-title>Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: Results of a controlled study in healthy volunteers</article-title><source>Eur. J. Clin. Nutr.</source><year>2007</year><volume>61</volume><fpage>314</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602523</pub-id><?supplied-pmid 16969378?><pub-id pub-id-type="pmid">16969378</pub-id></element-citation></ref><ref id="B56-nutrients-10-01561"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mustad</surname><given-names>V.A.</given-names></name><name><surname>Demichele</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>Y.S.</given-names></name><name><surname>Mika</surname><given-names>A.</given-names></name><name><surname>Lubbers</surname><given-names>N.</given-names></name><name><surname>Berthiaume</surname><given-names>N.</given-names></name><name><surname>Polakowski</surname><given-names>J.</given-names></name><name><surname>Zinker</surname><given-names>B.</given-names></name></person-group><article-title>Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse</article-title><source>Metabolism</source><year>2006</year><volume>55</volume><fpage>1365</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2006.06.007</pub-id><?supplied-pmid 16979408?><pub-id pub-id-type="pmid">16979408</pub-id></element-citation></ref><ref id="B57-nutrients-10-01561"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>A.H.</given-names></name><name><surname>Reifen</surname><given-names>R.</given-names></name><name><surname>Crawford</surname><given-names>M.A.</given-names></name></person-group><article-title>Past and present insights on alpha linolenic acid and the omega-3 fatty acid family</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2016</year><volume>56</volume><fpage>2261</fpage><lpage>2267</lpage><pub-id pub-id-type="doi">10.1080/10408398.2013.828678</pub-id><?supplied-pmid 25774650?><pub-id pub-id-type="pmid">25774650</pub-id></element-citation></ref><ref id="B58-nutrients-10-01561"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goyens</surname><given-names>P.L.</given-names></name><name><surname>Spilker</surname><given-names>M.E.</given-names></name><name><surname>Zock</surname><given-names>P.L.</given-names></name><name><surname>Katan</surname><given-names>M.B.</given-names></name><name><surname>Mensink</surname><given-names>R.P.</given-names></name></person-group><article-title>Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio</article-title><source>Am. J. Clin. Nutr.</source><year>2006</year><volume>84</volume><fpage>44</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1093/ajcn/84.1.44</pub-id><?supplied-pmid 16825680?><pub-id pub-id-type="pmid">16825680</pub-id></element-citation></ref><ref id="B59-nutrients-10-01561"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goyens</surname><given-names>P.L.</given-names></name><name><surname>Mensink</surname><given-names>R.P.</given-names></name></person-group><article-title>Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects</article-title><source>Eur. J. Clin. Nutr.</source><year>2006</year><volume>60</volume><fpage>978</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602408</pub-id><?supplied-pmid 16482073?><pub-id pub-id-type="pmid">16482073</pub-id></element-citation></ref><ref id="B60-nutrients-10-01561"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>P.</given-names></name><name><surname>Raederstorff</surname><given-names>D.</given-names></name></person-group><article-title>Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids&#x02014;A review</article-title><source>Nutr. Metab. Cardiovasc. Dis.</source><year>2000</year><volume>10</volume><fpage>28</fpage><lpage>37</lpage><?supplied-pmid 10812585?><pub-id pub-id-type="pmid">10812585</pub-id></element-citation></ref><ref id="B61-nutrients-10-01561"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>D.D.</given-names></name><name><surname>Miller</surname><given-names>P.E.</given-names></name><name><surname>Van Elswyk</surname><given-names>M.E.</given-names></name><name><surname>Kuratko</surname><given-names>C.N.</given-names></name><name><surname>Bylsma</surname><given-names>L.C.</given-names></name></person-group><article-title>A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk</article-title><source>Mayo Clin. Proc.</source><year>2017</year><volume>92</volume><fpage>15</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.mayocp.2016.10.018</pub-id><?supplied-pmid 28062061?><pub-id pub-id-type="pmid">28062061</pub-id></element-citation></ref><ref id="B62-nutrients-10-01561"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nambi</surname><given-names>V.</given-names></name><name><surname>Ballantyne</surname><given-names>C.M.</given-names></name></person-group><article-title>Combination therapy with statins and omega-3 fatty acids</article-title><source>Am. J. Cardiol.</source><year>2006</year><volume>98</volume><fpage>34i</fpage><lpage>38i</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2005.12.025</pub-id><?supplied-pmid 16919515?><pub-id pub-id-type="pmid">16919515</pub-id></element-citation></ref><ref id="B63-nutrients-10-01561"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>Y.</given-names></name><name><surname>Harris</surname><given-names>W.S.</given-names></name></person-group><article-title>Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance</article-title><source>J. Lipid Res.</source><year>2003</year><volume>44</volume><fpage>455</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1194/jlr.M200282-JLR200</pub-id><?supplied-pmid 12562865?><pub-id pub-id-type="pmid">12562865</pub-id></element-citation></ref><ref id="B64-nutrients-10-01561"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>M.H.</given-names></name><name><surname>Stein</surname><given-names>E.A.</given-names></name><name><surname>Bays</surname><given-names>H.E.</given-names></name><name><surname>Maki</surname><given-names>K.C.</given-names></name><name><surname>Doyle</surname><given-names>R.T.</given-names></name><name><surname>Shalwitz</surname><given-names>R.A.</given-names></name><name><surname>Ballantyne</surname><given-names>C.M.</given-names></name><name><surname>Ginsberg</surname><given-names>H.N.</given-names></name></person-group><article-title>Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study</article-title><source>Clin. Ther.</source><year>2007</year><volume>29</volume><fpage>1354</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2007.07.018</pub-id><?supplied-pmid 17825687?><pub-id pub-id-type="pmid">17825687</pub-id></element-citation></ref><ref id="B65-nutrients-10-01561"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Micallef</surname><given-names>M.A.</given-names></name><name><surname>Garga</surname><given-names>M.L.</given-names></name></person-group><article-title>Beyond blood lipids: Phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia</article-title><source>J. Nutr. Biochem.</source><year>2009</year><volume>20</volume><fpage>927</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2009.06.009</pub-id><?supplied-pmid 19733044?><pub-id pub-id-type="pmid">19733044</pub-id></element-citation></ref><ref id="B66-nutrients-10-01561"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ignarro</surname><given-names>L.J.</given-names></name><name><surname>Balestrieri</surname><given-names>M.L.</given-names></name><name><surname>Napoli</surname><given-names>C.</given-names></name></person-group><article-title>Nutrition, physical activity, and cardiovascular disease: An update</article-title><source>Cardiovasc. Res.</source><year>2007</year><volume>73</volume><fpage>326</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2006.06.030</pub-id><?supplied-pmid 16945357?><pub-id pub-id-type="pmid">16945357</pub-id></element-citation></ref><ref id="B67-nutrients-10-01561"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badimon</surname><given-names>L.</given-names></name><name><surname>Vilahur</surname><given-names>G.</given-names></name><name><surname>Padro</surname><given-names>T.</given-names></name></person-group><article-title>Nutraceuticals and atherosclerosis: Human trials</article-title><source>Cardiovasc. Ther.</source><year>2010</year><volume>28</volume><fpage>202</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1111/j.1755-5922.2010.00189.x</pub-id><?supplied-pmid 20633023?><pub-id pub-id-type="pmid">20633023</pub-id></element-citation></ref><ref id="B68-nutrients-10-01561"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>N.</given-names></name><name><surname>Guevara-Cruz</surname><given-names>M.</given-names></name><name><surname>Velazquez-Villegas</surname><given-names>L.A.</given-names></name><name><surname>Tovar</surname><given-names>A.R.</given-names></name></person-group><article-title>Nutrition and atherosclerosis</article-title><source>Arch. Med. Res.</source><year>2015</year><volume>46</volume><fpage>408</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1016/j.arcmed.2015.05.010</pub-id><?supplied-pmid 26031780?><pub-id pub-id-type="pmid">26031780</pub-id></element-citation></ref><ref id="B69-nutrients-10-01561"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Luo</surname><given-names>C.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Deng</surname><given-names>Q.</given-names></name><name><surname>Zheng</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name></person-group><article-title>Flaxseed oil containing alpha-linolenic acid ester of plant sterol improved atherosclerosis in ApoE deficient mice</article-title><source>Oxid. Med. Cell. Longev.</source><year>2015</year><pub-id pub-id-type="doi">10.1155/2015/958217</pub-id><?supplied-pmid 26180602?><pub-id pub-id-type="pmid">26180602</pub-id></element-citation></ref><ref id="B70-nutrients-10-01561"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>M.S.</given-names></name><name><surname>Kessuane</surname><given-names>M.C.</given-names></name><name><surname>Lobo Ladd</surname><given-names>A.A.</given-names></name><name><surname>Lobo Ladd</surname><given-names>F.V.</given-names></name><name><surname>Cogliati</surname><given-names>B.</given-names></name><name><surname>Castro</surname><given-names>I.A.</given-names></name></person-group><article-title>Effect of long-term ingestion of weakly oxidised flaxseed oil on biomarkers of oxidative stress in LDL-receptor knockout mice</article-title><source>Br. J. Nutr.</source><year>2016</year><volume>116</volume><fpage>258</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1017/S0007114516001513</pub-id><?supplied-pmid 27197628?><pub-id pub-id-type="pmid">27197628</pub-id></element-citation></ref><ref id="B71-nutrients-10-01561"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>K.</given-names></name></person-group><article-title>Flaxseed and cardiovascular health</article-title><source>J. Cardiovasc. Pharmacol.</source><year>2009</year><volume>54</volume><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1097/FJC.0b013e3181af04e5</pub-id><?supplied-pmid 19568181?><pub-id pub-id-type="pmid">19568181</pub-id></element-citation></ref><ref id="B72-nutrients-10-01561"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Din</surname><given-names>J.N.</given-names></name><name><surname>Newby</surname><given-names>D.E.</given-names></name><name><surname>Flapan</surname><given-names>A.D.</given-names></name></person-group><article-title>Omega 3 fatty acids and cardiovascular disease&#x02014;Fishing for a natural treatment</article-title><source>BMJ</source><year>2004</year><volume>328</volume><fpage>30</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1136/bmj.328.7430.30</pub-id><?supplied-pmid 14703544?><pub-id pub-id-type="pmid">14703544</pub-id></element-citation></ref><ref id="B73-nutrients-10-01561"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostowik</surname><given-names>M.</given-names></name><name><surname>Gajos</surname><given-names>G.</given-names></name><name><surname>Zalewski</surname><given-names>J.</given-names></name><name><surname>Nessler</surname><given-names>J.</given-names></name><name><surname>Undas</surname><given-names>A.</given-names></name></person-group><article-title>Omega-3 polyunsaturated fatty acids increase plasma adiponectin to leptin ratio in stable coronary artery disease</article-title><source>Cardiovasc. Drugs Ther.</source><year>2013</year><volume>27</volume><fpage>289</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1007/s10557-013-6457-x</pub-id><?supplied-pmid 23584593?><pub-id pub-id-type="pmid">23584593</pub-id></element-citation></ref><ref id="B74-nutrients-10-01561"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>T.A.</given-names></name></person-group><article-title>Dietary n-3 PUFA and CVD: A review of the evidence</article-title><source>Proc. Nutr. Soc.</source><year>2014</year><volume>73</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1017/S0029665113003583</pub-id><?supplied-pmid 24119287?><pub-id pub-id-type="pmid">24119287</pub-id></element-citation></ref><ref id="B75-nutrients-10-01561"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>B.B.</given-names></name><name><surname>Cameron-Smith</surname><given-names>D.</given-names></name><name><surname>Hofman</surname><given-names>P.L.</given-names></name><name><surname>Cutfield</surname><given-names>W.S.</given-names></name></person-group><article-title>Oxidation of marine omega-3 supplements and human health</article-title><source>Biomed. Res. Int.</source><year>2013</year><volume>2013</volume><fpage>464921</fpage><pub-id pub-id-type="doi">10.1155/2013/464921</pub-id><?supplied-pmid 23738326?><pub-id pub-id-type="pmid">23738326</pub-id></element-citation></ref><ref id="B76-nutrients-10-01561"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Wanga</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Shanga</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhong</surname><given-names>M.</given-names></name></person-group><article-title>The limited effect of omega-3 polyunsaturated fatty acids on cardiovascular risk in patients with impaired glucose metabolism: A meta-analysis</article-title><source>Clin. Biochem.</source><year>2014</year><volume>47</volume><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2013.11.025</pub-id><?supplied-pmid 24342751?><pub-id pub-id-type="pmid">24342751</pub-id></element-citation></ref><ref id="B77-nutrients-10-01561"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gajos</surname><given-names>G.</given-names></name><name><surname>Zalewski</surname><given-names>J.</given-names></name><name><surname>Rostoff</surname><given-names>P.</given-names></name><name><surname>Nessler</surname><given-names>J.</given-names></name><name><surname>Piwowarska</surname><given-names>W.</given-names></name><name><surname>Undas</surname><given-names>A.</given-names></name></person-group><article-title>Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot)</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><year>2011</year><volume>31</volume><fpage>1696</fpage><lpage>1702</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.111.228593</pub-id><?supplied-pmid 21617138?><pub-id pub-id-type="pmid">21617138</pub-id></element-citation></ref><ref id="B78-nutrients-10-01561"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gajos</surname><given-names>G.</given-names></name><name><surname>Rostoff</surname><given-names>P.</given-names></name><name><surname>Undas</surname><given-names>A.</given-names></name><name><surname>Piwowarska</surname><given-names>W.</given-names></name></person-group><article-title>Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: The OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study</article-title><source>J. Am. Coll. Cardiol.</source><year>2010</year><volume>55</volume><fpage>1671</fpage><lpage>1678</lpage><?supplied-pmid 20394870?><pub-id pub-id-type="pmid">20394870</pub-id></element-citation></ref><ref id="B79-nutrients-10-01561"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gajos</surname><given-names>G.</given-names></name><name><surname>Zalewski</surname><given-names>J.</given-names></name><name><surname>Nessler</surname><given-names>J.</given-names></name><name><surname>Zmudka</surname><given-names>K.</given-names></name><name><surname>Undas</surname><given-names>A.</given-names></name><name><surname>Piwowarska</surname><given-names>W.</given-names></name></person-group><article-title>Polyunsaturated omega-3 fatty acids improve responsiveness to clopidogrel after percutaneous coronary intervention in patients with cytochrome P450 2C19 loss-of-function polymorphism</article-title><source>Kardiol. Pol.</source><year>2012</year><volume>70</volume><fpage>439</fpage><lpage>445</lpage><?supplied-pmid 22623230?><pub-id pub-id-type="pmid">22623230</pub-id></element-citation></ref><ref id="B80-nutrients-10-01561"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorich</surname><given-names>M.J.</given-names></name><name><surname>Vitry</surname><given-names>A.</given-names></name><name><surname>Ward</surname><given-names>M.B.</given-names></name><name><surname>Horowitz</surname><given-names>J.D.</given-names></name><name><surname>McKinnon</surname><given-names>R.A.</given-names></name></person-group><article-title>Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: Integration of the TRITON-TIMI 38 trial data</article-title><source>J. Thromb. Haemost.</source><year>2010</year><volume>8</volume><fpage>1678</fpage><lpage>1684</lpage><pub-id pub-id-type="doi">10.1111/j.1538-7836.2010.03923.x</pub-id><?supplied-pmid 20492467?><pub-id pub-id-type="pmid">20492467</pub-id></element-citation></ref><ref id="B81-nutrients-10-01561"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Din</surname><given-names>J.N.</given-names></name><name><surname>Harding</surname><given-names>S.A.</given-names></name><name><surname>Valerio</surname><given-names>C.J.</given-names></name><name><surname>Sarma</surname><given-names>J.</given-names></name><name><surname>Lyall</surname><given-names>K.</given-names></name><name><surname>Riemersma</surname><given-names>R.A.</given-names></name><name><surname>Newby</surname><given-names>D.E.</given-names></name><name><surname>Flapan</surname><given-names>A.D.</given-names></name></person-group><article-title>Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man</article-title><source>Atherosclerosis</source><year>2008</year><volume>197</volume><fpage>290</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2007.04.047</pub-id><?supplied-pmid 17575985?><pub-id pub-id-type="pmid">17575985</pub-id></element-citation></ref><ref id="B82-nutrients-10-01561"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamez</surname><given-names>R.</given-names></name><name><surname>Maz</surname><given-names>R.</given-names></name><name><surname>Arruzazabala</surname><given-names>M.L.</given-names></name><name><surname>Mendoza</surname><given-names>S.</given-names></name><name><surname>Castano</surname><given-names>G.</given-names></name></person-group><article-title>Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits</article-title><source>Drugs RD</source><year>2005</year><volume>6</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.2165/00126839-200506010-00002</pub-id></element-citation></ref><ref id="B83-nutrients-10-01561"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castano</surname><given-names>G.</given-names></name><name><surname>Fernandez</surname><given-names>L.</given-names></name><name><surname>Mas</surname><given-names>R.</given-names></name><name><surname>Illnait</surname><given-names>J.</given-names></name><name><surname>Games</surname><given-names>R.</given-names></name><name><surname>Mendoza</surname><given-names>S.</given-names></name><name><surname>Mesa</surname><given-names>M.</given-names></name><name><surname>Fernandez</surname><given-names>J.</given-names></name></person-group><article-title>Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia</article-title><source>Drugs RD</source><year>2005</year><volume>6</volume><fpage>207</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.2165/00126839-200506040-00003</pub-id></element-citation></ref><ref id="B84-nutrients-10-01561"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castano</surname><given-names>G.</given-names></name><name><surname>Arruzazabala</surname><given-names>M.L.</given-names></name><name><surname>Fernandez</surname><given-names>L.</given-names></name><name><surname>Mas</surname><given-names>R.</given-names></name><name><surname>Carbajal</surname><given-names>D.</given-names></name><name><surname>Molina</surname><given-names>V.</given-names></name><name><surname>Illnait</surname><given-names>J.</given-names></name><name><surname>Mendoza</surname><given-names>S.</given-names></name><name><surname>Games</surname><given-names>R.</given-names></name><name><surname>Mesa</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study</article-title><source>Curr. Ther. Res. Clin. Exp.</source><year>2006</year><volume>67</volume><fpage>174</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.curtheres.2006.06.004</pub-id><?supplied-pmid 24678094?><pub-id pub-id-type="pmid">24678094</pub-id></element-citation></ref><ref id="B85-nutrients-10-01561"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>J.H.</given-names></name></person-group><article-title>Omega-3 fatty acids and cardiovascular disease: Effects on risk factors, molecular pathways, and clinical events</article-title><source>J. Am. Coll. Cardiol.</source><year>2011</year><volume>58</volume><fpage>2047</fpage><lpage>2067</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2011.06.063</pub-id><?supplied-pmid 22051327?><pub-id pub-id-type="pmid">22051327</pub-id></element-citation></ref><ref id="B86-nutrients-10-01561"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Schacky</surname><given-names>C.</given-names></name></person-group><article-title>Omega-3 fatty acids: Antiarrhythmic, proarrhythmic or both?</article-title><source>Curr. Opin. Clin. Nutr. Metab. Care</source><year>2008</year><volume>11</volume><fpage>94</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1097/MCO.0b013e3282f44bdf</pub-id><?supplied-pmid 18301082?><pub-id pub-id-type="pmid">18301082</pub-id></element-citation></ref><ref id="B87-nutrients-10-01561"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Leiris</surname><given-names>J.</given-names></name><name><surname>de Lorgeril</surname><given-names>M.</given-names></name><name><surname>Boucher</surname><given-names>F.</given-names></name></person-group><article-title>Fish oil and heart health</article-title><source>J. Cardiovasc. Pharmacol.</source><year>2009</year><volume>54</volume><fpage>378</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1097/FJC.0b013e3181af6c56</pub-id><?supplied-pmid 19568180?><pub-id pub-id-type="pmid">19568180</pub-id></element-citation></ref><ref id="B88-nutrients-10-01561"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saremi</surname><given-names>A.</given-names></name><name><surname>Arora</surname><given-names>R.</given-names></name></person-group><article-title>The utility of omega-3 fatty acids in cardiovascular disease</article-title><source>Am. J. Ther.</source><year>2009</year><volume>16</volume><fpage>421</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1097/MJT.0b013e3180a5f0bb</pub-id><?supplied-pmid 19092647?><pub-id pub-id-type="pmid">19092647</pub-id></element-citation></ref><ref id="B89-nutrients-10-01561"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodkowski</surname><given-names>R.</given-names></name><name><surname>Patkowska-Soko&#x00142;a</surname><given-names>B.</given-names></name><name><surname>Walisiewicz-Niedbalska</surname><given-names>W.</given-names></name><name><surname>Usydus</surname><given-names>Z.</given-names></name></person-group><article-title>The composition of bioactive lipid complex reducing the level of blood atherogenic lipid indices</article-title><source>Przem. Chem.</source><year>2010</year><volume>89</volume><fpage>304</fpage><lpage>310</lpage></element-citation></ref><ref id="B90-nutrients-10-01561"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianconi</surname><given-names>L.</given-names></name><name><surname>Cal&#x000f2;</surname><given-names>L.</given-names></name><name><surname>Mennuni</surname><given-names>M.</given-names></name><name><surname>Santini</surname><given-names>L.</given-names></name><name><surname>Morosetti</surname><given-names>P.</given-names></name><name><surname>Azzolini</surname><given-names>P.</given-names></name><name><surname>Barbato</surname><given-names>G.</given-names></name><name><surname>Biscione</surname><given-names>F.</given-names></name><name><surname>Romano</surname><given-names>P.</given-names></name><name><surname>Santini</surname><given-names>M.</given-names></name></person-group><article-title>N-3 Polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: A randomized, double-blind, multicentre study</article-title><source>EP Europace</source><year>2011</year><volume>13</volume><fpage>174</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1093/europace/euq386</pub-id><?supplied-pmid 21059740?><pub-id pub-id-type="pmid">21059740</pub-id></element-citation></ref><ref id="B91-nutrients-10-01561"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endo</surname><given-names>J.</given-names></name><name><surname>Arita</surname><given-names>M.</given-names></name></person-group><article-title>Cardioprotective mechanism of omega-3 polyunsaturated fatty acids</article-title><source>J. Cardiol.</source><year>2016</year><volume>67</volume><fpage>22</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.jjcc.2015.08.002</pub-id><?supplied-pmid 26359712?><pub-id pub-id-type="pmid">26359712</pub-id></element-citation></ref><ref id="B92-nutrients-10-01561"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiffel</surname><given-names>J.A.</given-names></name><name><surname>McDonald</surname><given-names>A.</given-names></name></person-group><article-title>Antiarrhythmic effects of omega-3 fatty acids</article-title><source>Am. J. Cardiol.</source><year>2006</year><volume>98</volume><fpage>50i</fpage><lpage>60i</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2005.12.027</pub-id><?supplied-pmid 16919517?><pub-id pub-id-type="pmid">16919517</pub-id></element-citation></ref><ref id="B93-nutrients-10-01561"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billman</surname><given-names>G.E.</given-names></name></person-group><article-title>The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: A critical reassessment</article-title><source>Pharmacol. Ther.</source><year>2013</year><volume>140</volume><fpage>53</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2013.05.011</pub-id><?supplied-pmid 23735203?><pub-id pub-id-type="pmid">23735203</pub-id></element-citation></ref><ref id="B94-nutrients-10-01561"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhupathiraju</surname><given-names>S.N.</given-names></name><name><surname>Tucker</surname><given-names>K.L.</given-names></name></person-group><article-title>Coronary heart disease prevention: Nutrients, foods, and dietary patterns</article-title><source>Clin. Chim. Acta</source><year>2011</year><volume>412</volume><fpage>1493</fpage><lpage>1514</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2011.04.038</pub-id><?supplied-pmid 21575619?><pub-id pub-id-type="pmid">21575619</pub-id></element-citation></ref><ref id="B95-nutrients-10-01561"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosso</surname><given-names>G.</given-names></name><name><surname>Marventano</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Micek</surname><given-names>A.</given-names></name><name><surname>Pajak</surname><given-names>A.</given-names></name><name><surname>Scalfi</surname><given-names>L.</given-names></name><name><surname>Galvano</surname><given-names>F.</given-names></name><name><surname>Kales</surname><given-names>S.N.</given-names></name></person-group><article-title>A comprehensive meta-analysis on evidence of Mediterranean diet and cardiovascular disease: Are individual components equal?</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2017</year><volume>57</volume><fpage>3218</fpage><lpage>3232</lpage><pub-id pub-id-type="doi">10.1080/10408398.2015.1107021</pub-id><?supplied-pmid 26528631?><pub-id pub-id-type="pmid">26528631</pub-id></element-citation></ref><ref id="B96-nutrients-10-01561"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhein</surname><given-names>S.</given-names></name><name><surname>Michaelis</surname><given-names>B.</given-names></name><name><surname>Mohr</surname><given-names>F.W.</given-names></name></person-group><article-title>Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids</article-title><source>Naunyn Schmiedebergs Arch. Pharmacol.</source><year>2005</year><volume>371</volume><fpage>202</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1007/s00210-005-1024-z</pub-id><?supplied-pmid 15900514?><pub-id pub-id-type="pmid">15900514</pub-id></element-citation></ref><ref id="B97-nutrients-10-01561"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guizy</surname><given-names>M.</given-names></name><name><surname>David</surname><given-names>M.</given-names></name><name><surname>Arias</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Cof&#x000e1;n</surname><given-names>M.</given-names></name><name><surname>Ruiz-Guti&#x000e9;rrez</surname><given-names>V.</given-names></name><name><surname>Ros</surname><given-names>E.</given-names></name><name><surname>Pilar Lillo</surname><given-names>M.</given-names></name><name><surname>Martens</surname><given-names>J.R.</given-names></name><name><surname>Valenzuela</surname><given-names>C.</given-names></name></person-group><article-title>Modulation of the atrial specific Kv1.5 channel by the n-3 polyunsaturated fatty acid, &#x003b1;-linolenic acid</article-title><source>J. Mol. Cell. Cardiol.</source><year>2008</year><volume>44</volume><fpage>323</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2007.11.004</pub-id><?supplied-pmid 18155022?><pub-id pub-id-type="pmid">18155022</pub-id></element-citation></ref><ref id="B98-nutrients-10-01561"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assmann</surname><given-names>G.</given-names></name><name><surname>Gotto</surname><given-names>A.M.</given-names><suffix>Jr.</suffix></name></person-group><article-title>HDL cholesterol and protective factors in atherosclerosis</article-title><source>Circulation</source><year>2004</year><volume>109</volume><fpage>III8</fpage><lpage>III14</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000131512.50667.46</pub-id><?supplied-pmid 15198960?><pub-id pub-id-type="pmid">15198960</pub-id></element-citation></ref><ref id="B99-nutrients-10-01561"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rye</surname><given-names>K.A.</given-names></name><name><surname>Barter</surname><given-names>P.J.</given-names></name></person-group><article-title>Cardioprotective functions of HDLs</article-title><source>J. Lipid Res.</source><year>2014</year><volume>55</volume><fpage>168</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1194/jlr.R039297</pub-id><?supplied-pmid 23812558?><pub-id pub-id-type="pmid">23812558</pub-id></element-citation></ref><ref id="B100-nutrients-10-01561"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Annema</surname><given-names>W.</given-names></name><name><surname>Tietge</surname><given-names>U.J.F.</given-names></name></person-group><article-title>Regulation of reverse cholesterol transport&#x02014;A comprehensive appraisal of available animal studies</article-title><source>Nutr. Metab.</source><year>2012</year><volume>9</volume><fpage>25</fpage><pub-id pub-id-type="doi">10.1186/1743-7075-9-25</pub-id><?supplied-pmid 22458435?><pub-id pub-id-type="pmid">22458435</pub-id></element-citation></ref><ref id="B101-nutrients-10-01561"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demonty</surname><given-names>I.</given-names></name><name><surname>Chan</surname><given-names>Y.M.</given-names></name><name><surname>Pelled</surname><given-names>D.</given-names></name><name><surname>Jones</surname><given-names>P.J.</given-names></name></person-group><article-title>Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols</article-title><source>Am. J. Clin. Nutr.</source><year>2006</year><volume>84</volume><fpage>1534</fpage><lpage>1542</lpage><pub-id pub-id-type="doi">10.1093/ajcn/84.6.1534</pub-id><?supplied-pmid 17158440?><pub-id pub-id-type="pmid">17158440</pub-id></element-citation></ref><ref id="B102-nutrients-10-01561"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palade</surname><given-names>F.</given-names></name><name><surname>Alexa</surname><given-names>I.D.</given-names></name><name><surname>Azoicai</surname><given-names>D.</given-names></name><name><surname>Panaghiu</surname><given-names>L.</given-names></name><name><surname>Ungureanu</surname><given-names>G.</given-names></name></person-group><article-title>Oxidative stress in atherosclerosis</article-title><source>Rev. Med. Chir. Soc. Med. Nat. Iasi</source><year>2003</year><volume>107</volume><fpage>502</fpage><lpage>511</lpage><?supplied-pmid 14756052?><pub-id pub-id-type="pmid">14756052</pub-id></element-citation></ref><ref id="B103-nutrients-10-01561"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>A.H.</given-names></name></person-group><article-title>Dietary fat and cardiovascular disease risk: Quantity or quality?</article-title><source>J. Womens Health</source><year>2003</year><volume>12</volume><fpage>109</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1089/154099903321576493</pub-id><?supplied-pmid 12737709?><pub-id pub-id-type="pmid">12737709</pub-id></element-citation></ref><ref id="B104-nutrients-10-01561"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname><given-names>M.</given-names></name><name><surname>Berneis</surname><given-names>K.</given-names></name></person-group><article-title>Who needs to care about small, dense low-density lipoproteins?</article-title><source>Int. J. Clin. Pract.</source><year>2007</year><volume>61</volume><fpage>1949</fpage><lpage>1956</lpage><pub-id pub-id-type="doi">10.1111/j.1742-1241.2007.01596.x</pub-id><?supplied-pmid 17935554?><pub-id pub-id-type="pmid">17935554</pub-id></element-citation></ref><ref id="B105-nutrients-10-01561"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>I.A.</given-names></name><name><surname>Katan</surname><given-names>M.B.</given-names></name><name><surname>Zock</surname><given-names>P.L.</given-names></name></person-group><article-title>Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: A meta-analysis</article-title><source>J. Nutr.</source><year>2004</year><volume>134</volume><fpage>919</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.1093/jn/134.4.919</pub-id><?supplied-pmid 15051847?><pub-id pub-id-type="pmid">15051847</pub-id></element-citation></ref><ref id="B106-nutrients-10-01561"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weitz</surname><given-names>D.</given-names></name><name><surname>Weintraub</surname><given-names>H.</given-names></name><name><surname>Fisher</surname><given-names>E.</given-names></name><name><surname>Schwartzbard</surname><given-names>A.Z.</given-names></name></person-group><article-title>Fish oil for the treatment of cardiovascular disease</article-title><source>Cardiol. Rev.</source><year>2010</year><volume>18</volume><fpage>258</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1097/CRD.0b013e3181ea0de0</pub-id><?supplied-pmid 20699674?><pub-id pub-id-type="pmid">20699674</pub-id></element-citation></ref><ref id="B107-nutrients-10-01561"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Koh</surname><given-names>W.P.</given-names></name><name><surname>Yuan</surname><given-names>J.M.</given-names></name><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Ong</surname><given-names>C.N.</given-names></name><name><surname>van Dam</surname><given-names>R.M.</given-names></name></person-group><article-title>Plasma alpha-linolenic and long-chain omega-3 fatty acids are associated with a lower risk of acute myocardial infarction in Singapore Chinese adults</article-title><source>J. Nutr.</source><year>2016</year><volume>146</volume><fpage>275</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.3945/jn.115.220418</pub-id><?supplied-pmid 26609174?><pub-id pub-id-type="pmid">26609174</pub-id></element-citation></ref><ref id="B108-nutrients-10-01561"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derbali</surname><given-names>A.</given-names></name><name><surname>Mnafgui</surname><given-names>K.</given-names></name><name><surname>Affes</surname><given-names>M.</given-names></name><name><surname>Derbali</surname><given-names>F.</given-names></name><name><surname>Hajji</surname><given-names>R.</given-names></name><name><surname>Gharsallah</surname><given-names>N.</given-names></name><name><surname>Allouche</surname><given-names>N.</given-names></name><name><surname>El Feki</surname><given-names>A.</given-names></name></person-group><article-title>Cardioprotective effect of linseed oil against isoproterenol-induced myocardial infarction in Wistar rats: A biochemical and electrocardiographic study</article-title><source>J. Physiol. Biochem.</source><year>2015</year><volume>71</volume><fpage>281</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1007/s13105-015-0411-2</pub-id><?supplied-pmid 25910460?><pub-id pub-id-type="pmid">25910460</pub-id></element-citation></ref><ref id="B109-nutrients-10-01561"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoni-Berisso</surname><given-names>M.</given-names></name><name><surname>Lercari</surname><given-names>F.</given-names></name><name><surname>Carazza</surname><given-names>T.</given-names></name><name><surname>Domenicucci</surname><given-names>S.</given-names></name></person-group><article-title>Epidemiology of atrial fibrillation: European perspective</article-title><source>Clin. Epidemiol.</source><year>2014</year><volume>6</volume><fpage>213</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.2147/CLEP.S47385</pub-id><?supplied-pmid 24966695?><pub-id pub-id-type="pmid">24966695</pub-id></element-citation></ref><ref id="B110-nutrients-10-01561"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fretts</surname><given-names>A.M.</given-names></name><name><surname>Mozaffarian</surname><given-names>D.</given-names></name><name><surname>Siscovick</surname><given-names>D.S.</given-names></name><name><surname>Heckbert</surname><given-names>S.R.</given-names></name><name><surname>McKnight</surname><given-names>B.</given-names></name><name><surname>King</surname><given-names>I.B.</given-names></name><name><surname>Rimm</surname><given-names>E.B.</given-names></name><name><surname>Psaty</surname><given-names>B.M.</given-names></name><name><surname>Sacks</surname><given-names>F.M.</given-names></name><name><surname>Song</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Associations of plasma phospholipid and dietary alpha linolenic acid with incident atrial fibrillation in older adults: The Cardiovascular Health Study</article-title><source>J. Am. Heart Assoc.</source><year>2013</year><volume>2</volume><fpage>e003814</fpage><pub-id pub-id-type="doi">10.1161/JAHA.112.003814</pub-id><?supplied-pmid 23525429?><pub-id pub-id-type="pmid">23525429</pub-id></element-citation></ref><ref id="B111-nutrients-10-01561"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kastner</surname><given-names>D.W.</given-names></name><name><surname>Van Wagoner</surname><given-names>D.R.</given-names></name></person-group><article-title>Diet and atrial fibrillation: Does &#x003b1;-linolenic acid, a plant derived essential fatty acid, have an impact?</article-title><source>J. Am. Heart Assoc.</source><year>2013</year><volume>2</volume><fpage>e000030</fpage><pub-id pub-id-type="doi">10.1161/JAHA.112.000030</pub-id><?supplied-pmid 23525415?><pub-id pub-id-type="pmid">23525415</pub-id></element-citation></ref><ref id="B112-nutrients-10-01561"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilk</surname><given-names>J.B.</given-names></name><name><surname>Tsai</surname><given-names>M.Y.</given-names></name><name><surname>Hanson</surname><given-names>N.Q.</given-names></name><name><surname>Gaziano</surname><given-names>J.M.</given-names></name><name><surname>Djousse</surname><given-names>L.</given-names></name></person-group><article-title>Plasma and dietary omega-3 fatty acids, fish intake, and heart failure risk in the Physicians&#x02019; Health Study</article-title><source>Am. J. Clin. Nutr.</source><year>2012</year><volume>96</volume><fpage>882</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.3945/ajcn.112.042671</pub-id><?supplied-pmid 22952185?><pub-id pub-id-type="pmid">22952185</pub-id></element-citation></ref><ref id="B113-nutrients-10-01561"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calo</surname><given-names>L.</given-names></name><name><surname>Bianconi</surname><given-names>L.</given-names></name><name><surname>Colivicchi</surname><given-names>F.</given-names></name><name><surname>Lamberti</surname><given-names>F.</given-names></name><name><surname>Loricchio</surname><given-names>M.L.</given-names></name><name><surname>de Ruvo</surname><given-names>E.</given-names></name><name><surname>Meo</surname><given-names>A.</given-names></name><name><surname>Pandozi</surname><given-names>C.</given-names></name><name><surname>Staibano</surname><given-names>M.</given-names></name><name><surname>Santini</surname><given-names>M.</given-names></name></person-group><article-title>N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: A randomized, controlled trial</article-title><source>J. Am. Coll. Cardiol.</source><year>2005</year><volume>45</volume><fpage>1723</fpage><lpage>1728</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2005.02.079</pub-id><?supplied-pmid 15893193?><pub-id pub-id-type="pmid">15893193</pub-id></element-citation></ref><ref id="B114-nutrients-10-01561"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alqahtani</surname><given-names>A.A.</given-names></name></person-group><article-title>Atrial fibrillation post cardiac surgery trends toward management</article-title><source>Heart Views</source><year>2010</year><volume>11</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.4103/1995-705X.73212</pub-id><?supplied-pmid 21187998?><pub-id pub-id-type="pmid">21187998</pub-id></element-citation></ref><ref id="B115-nutrients-10-01561"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folino</surname><given-names>A.</given-names></name><name><surname>Sprio</surname><given-names>A.E.</given-names></name><name><surname>Di Scipio</surname><given-names>F.</given-names></name><name><surname>Berta</surname><given-names>G.N.</given-names></name><name><surname>Rastaldo</surname><given-names>R.</given-names></name></person-group><article-title>Alpha-linolenic acid protects against cardiac injury and remodelling induced by beta-adrenergic overstimulation</article-title><source>Food Funct.</source><year>2015</year><volume>6</volume><fpage>2231</fpage><lpage>2239</lpage><pub-id pub-id-type="doi">10.1039/C5FO00034C</pub-id><?supplied-pmid 26068025?><pub-id pub-id-type="pmid">26068025</pub-id></element-citation></ref><ref id="B116-nutrients-10-01561"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Leak</surname><given-names>R.K.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>Omega-3 polyunsaturated fatty acids enhance cerebral angiogenesis and provide long-term protection after stroke</article-title><source>Neurobiol. Dis.</source><year>2014</year><volume>68</volume><fpage>91</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2014.04.014</pub-id><?supplied-pmid 24794156?><pub-id pub-id-type="pmid">24794156</pub-id></element-citation></ref><ref id="B117-nutrients-10-01561"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demaerschalk</surname><given-names>B.M.</given-names></name><name><surname>Hwang</surname><given-names>H.M.</given-names></name><name><surname>Leung</surname><given-names>G.</given-names></name></person-group><article-title>US cost burden of ischemic stroke: A systematic literature review</article-title><source>Am. J. Manag. Care</source><year>2010</year><volume>16</volume><fpage>525</fpage><lpage>533</lpage><?supplied-pmid 20645668?><pub-id pub-id-type="pmid">20645668</pub-id></element-citation></ref><ref id="B118-nutrients-10-01561"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiltrout</surname><given-names>C.</given-names></name><name><surname>Lang</surname><given-names>B.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Dempsey</surname><given-names>R.J.</given-names></name><name><surname>Vemuganti</surname><given-names>R.</given-names></name></person-group><article-title>Repairing brain after stroke: A review on post-ischemic neurogenesis</article-title><source>Neurochem. Int.</source><year>2007</year><volume>50</volume><fpage>1028</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2007.04.011</pub-id><?supplied-pmid 17531349?><pub-id pub-id-type="pmid">17531349</pub-id></element-citation></ref><ref id="B119-nutrients-10-01561"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.L.</given-names></name><name><surname>Chopp</surname><given-names>M.</given-names></name><name><surname>Roberts</surname><given-names>C.</given-names></name><name><surname>Jia</surname><given-names>L.</given-names></name><name><surname>Wei</surname><given-names>M.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Pourabdollah</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Z.G.</given-names></name></person-group><article-title>Ascl1 lineage cells contribute to ischemia-induced neurogenesis and oligodendrogenesis</article-title><source>J. Cereb. Blood Flow MeTable</source><year>2011</year><volume>31</volume><fpage>614</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1038/jcbfm.2010.134</pub-id><?supplied-pmid 20736965?><pub-id pub-id-type="pmid">20736965</pub-id></element-citation></ref><ref id="B120-nutrients-10-01561"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermann</surname><given-names>D.M.</given-names></name><name><surname>Chopp</surname><given-names>M.</given-names></name></person-group><article-title>Promoting brain remodelling and plasticity for stroke recovery: Therapeutic promise and potential pitfalls of clinical translation</article-title><source>Lancet Neurol.</source><year>2012</year><volume>11</volume><fpage>369</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(12)70039-X</pub-id><pub-id pub-id-type="pmid">22441198</pub-id></element-citation></ref><ref id="B121-nutrients-10-01561"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Akamatsu</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>C.C.</given-names></name><name><surname>Stetler</surname><given-names>R.A.</given-names></name><name><surname>Lawton</surname><given-names>M.T.</given-names></name><name><surname>Yang</surname><given-names>G.Y.</given-names></name></person-group><article-title>Vascular remodeling after ischemic stroke: Mechanisms and therapeutic potentials</article-title><source>Prog. Neurobiol.</source><year>2014</year><volume>115</volume><fpage>138</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2013.11.004</pub-id><?supplied-pmid 24291532?><pub-id pub-id-type="pmid">24291532</pub-id></element-citation></ref><ref id="B122-nutrients-10-01561"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaughlin</surname><given-names>B.</given-names></name><name><surname>Gidday</surname><given-names>J.M.</given-names></name></person-group><article-title>Poised for success: Implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients</article-title><source>Transl. Stroke Res.</source><year>2013</year><volume>4</volume><fpage>104</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1007/s12975-012-0240-3</pub-id><?supplied-pmid 24323191?><pub-id pub-id-type="pmid">24323191</pub-id></element-citation></ref><ref id="B123-nutrients-10-01561"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belayev</surname><given-names>L.</given-names></name><name><surname>Khoutorova</surname><given-names>L.</given-names></name><name><surname>Atkins</surname><given-names>K.D.</given-names></name><name><surname>Bazan</surname><given-names>N.G.</given-names></name></person-group><article-title>Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia</article-title><source>Stroke</source><year>2009</year><volume>40</volume><fpage>3121</fpage><lpage>3126</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.109.555979</pub-id><?supplied-pmid 19542051?><pub-id pub-id-type="pmid">19542051</pub-id></element-citation></ref><ref id="B124-nutrients-10-01561"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Leak</surname><given-names>R.K.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Iwai</surname><given-names>M.</given-names></name><name><surname>Stetler</surname><given-names>R.A.</given-names></name><name><surname>Dai</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>A.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>Transgenic overproduction of omega-3 polyunsaturated fatty acids provides neuroprotection and enhances endogenous neurogenesis after stroke</article-title><source>Curr. Mol. Med.</source><year>2013</year><volume>13</volume><fpage>1465</fpage><lpage>1473</lpage><pub-id pub-id-type="doi">10.2174/15665240113139990075</pub-id><?supplied-pmid 23971733?><pub-id pub-id-type="pmid">23971733</pub-id></element-citation></ref><ref id="B125-nutrients-10-01561"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>Omega-3 polyunsaturated fatty acid supplementation confers long-term neuroprotection against neonatal hypoxic-ischemic brain injury through anti-inflammatory actions</article-title><source>Stroke</source><year>2010</year><volume>41</volume><fpage>2341</fpage><lpage>2347</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.110.586081</pub-id><?supplied-pmid 20705927?><pub-id pub-id-type="pmid">20705927</pub-id></element-citation></ref><ref id="B126-nutrients-10-01561"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musiek</surname><given-names>E.S.</given-names></name><name><surname>Brooks</surname><given-names>J.D.</given-names></name><name><surname>Joo</surname><given-names>M.</given-names></name><name><surname>Brunoldi</surname><given-names>E.</given-names></name><name><surname>Porta</surname><given-names>A.</given-names></name><name><surname>Zanoni</surname><given-names>G.</given-names></name><name><surname>Vidari</surname><given-names>G.</given-names></name><name><surname>Blackwell</surname><given-names>T.S.</given-names></name><name><surname>Montine</surname><given-names>T.J.</given-names></name><name><surname>Milne</surname><given-names>G.L.</given-names></name><etal/></person-group><article-title>Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid</article-title><source>J. Biol. Chem.</source><year>2008</year><volume>283</volume><fpage>19927</fpage><lpage>19935</lpage><pub-id pub-id-type="doi">10.1074/jbc.M803625200</pub-id><?supplied-pmid 18490445?><pub-id pub-id-type="pmid">18490445</pub-id></element-citation></ref><ref id="B127-nutrients-10-01561"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazan</surname><given-names>N.G.</given-names></name></person-group><article-title>Neuroprotectin D1 (NPD1): A DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress</article-title><source>Brain Pathol.</source><year>2005</year><volume>15</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3639.2005.tb00513.x</pub-id><?supplied-pmid 15912889?><pub-id pub-id-type="pmid">15912889</pub-id></element-citation></ref><ref id="B128-nutrients-10-01561"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Mao</surname><given-names>L.</given-names></name><name><surname>Leak</surname><given-names>R.K.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Cao</surname><given-names>G.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Omega-3 fatty acids protect the brain against ischemic injury by activating Nrf2 and upregulating heme oxygenase 1</article-title><source>J. Neurosci.</source><year>2014</year><volume>34</volume><fpage>1903</fpage><lpage>1915</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4043-13.2014</pub-id><?supplied-pmid 24478369?><pub-id pub-id-type="pmid">24478369</pub-id></element-citation></ref><ref id="B129-nutrients-10-01561"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>T.D.</given-names></name><name><surname>Willhoite</surname><given-names>A.R.</given-names></name><name><surname>Gage</surname><given-names>F.H.</given-names></name></person-group><article-title>Vascular niche for adult hippocampal neurogenesis</article-title><source>J. Comp. Neurol.</source><year>2000</year><volume>425</volume><fpage>479</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1002/1096-9861(20001002)425:4&#x0003c;479::AID-CNE2&#x0003e;3.0.CO;2-3</pub-id><pub-id pub-id-type="pmid">10975875</pub-id></element-citation></ref><ref id="B130-nutrients-10-01561"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Leak</surname><given-names>R.K.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>Dietary supplementation with omega-3 polyunsaturated fatty acids robustly promotes neurovascular restorative dynamics and improves neurological functions after stroke</article-title><source>Exp. Neurol.</source><year>2015</year><volume>272</volume><fpage>170</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2015.03.005</pub-id><?supplied-pmid 25771800?><pub-id pub-id-type="pmid">25771800</pub-id></element-citation></ref><ref id="B131-nutrients-10-01561"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D.</given-names></name><name><surname>Lemaitre</surname><given-names>R.N.</given-names></name><name><surname>King</surname><given-names>I.B.</given-names></name><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Sacks</surname><given-names>F.M.</given-names></name><name><surname>Rimm</surname><given-names>E.B.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Siscovick</surname><given-names>D.S.</given-names></name></person-group><article-title>Plasma phospholipid long-chain omega-3 fatty acids and total and causespecific mortality in older adults: A cohort study</article-title><source>Ann. Intern. Med.</source><year>2013</year><volume>158</volume><fpage>515</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-158-7-201304020-00003</pub-id><?supplied-pmid 23546563?><pub-id pub-id-type="pmid">23546563</pub-id></element-citation></ref><ref id="B132-nutrients-10-01561"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname><given-names>S.C.</given-names></name><name><surname>Orsini</surname><given-names>N.</given-names></name></person-group><article-title>Fish consumption and the risk of stroke: A dose-response meta-analysis</article-title><source>Stroke</source><year>2011</year><volume>42</volume><fpage>3621</fpage><lpage>3623</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.111.630319</pub-id><?supplied-pmid 21903950?><pub-id pub-id-type="pmid">21903950</pub-id></element-citation></ref><ref id="B133-nutrients-10-01561"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>K.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Daviglus</surname><given-names>M.L.</given-names></name><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Van Horn</surname><given-names>L.</given-names></name><name><surname>Dyer</surname><given-names>A.R.</given-names></name><name><surname>Goldbourt</surname><given-names>U.</given-names></name><name><surname>Greenland</surname><given-names>P.</given-names></name></person-group><article-title>Fish consumption and incidence of stroke A meta-analysis of cohort studies</article-title><source>Stroke</source><year>2004</year><volume>35</volume><fpage>1538</fpage><lpage>1542</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000130856.31468.47</pub-id><?supplied-pmid 15155968?><pub-id pub-id-type="pmid">15155968</pub-id></element-citation></ref><ref id="B134-nutrients-10-01561"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizos</surname><given-names>E.C.</given-names></name><name><surname>Ntzani</surname><given-names>E.E.</given-names></name><name><surname>Bika</surname><given-names>E.</given-names></name><name><surname>Kostapanos</surname><given-names>M.S.</given-names></name><name><surname>Elisaf</surname><given-names>M.S.</given-names></name></person-group><article-title>Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis</article-title><source>JAMA</source><year>2012</year><volume>308</volume><fpage>1024</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1001/2012.jama.11374</pub-id><?supplied-pmid 22968891?><pub-id pub-id-type="pmid">22968891</pub-id></element-citation></ref><ref id="B135-nutrients-10-01561"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siscovick</surname><given-names>D.S.</given-names></name><name><surname>Barringer</surname><given-names>T.A.</given-names></name><name><surname>Amanda</surname><given-names>M.</given-names></name><name><surname>Fretts</surname><given-names>A.M.</given-names></name><name><surname>Wu</surname><given-names>J.H.Y.</given-names></name><name><surname>Lichtenstein</surname><given-names>A.H.</given-names></name><name><surname>Costello</surname><given-names>R.B.</given-names></name><name><surname>Kris-Etherton</surname><given-names>P.M.</given-names></name><name><surname>Jacobson</surname><given-names>T.A.</given-names></name><name><surname>Engler</surname><given-names>M.B.</given-names></name><etal/></person-group><article-title>Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease a science advisory from the American Heart Association</article-title><source>Circulation</source><year>2017</year><volume>135</volume><fpage>e867</fpage><lpage>e884</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000482</pub-id><?supplied-pmid 28289069?><pub-id pub-id-type="pmid">28289069</pub-id></element-citation></ref><ref id="B136-nutrients-10-01561"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname><given-names>S.M.</given-names></name><name><surname>Myung</surname><given-names>S.K.</given-names></name><name><surname>Lee</surname><given-names>Y.J.</given-names></name><name><surname>Seo</surname><given-names>H.G.</given-names></name></person-group><article-title>Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: A meta-analysis of randomized, double-blind, placebo-controlled trials</article-title><source>Arch. Intern. Med.</source><year>2012</year><volume>172</volume><fpage>686</fpage><lpage>694</lpage><?supplied-pmid 22493407?><pub-id pub-id-type="pmid">22493407</pub-id></element-citation></ref><ref id="B137-nutrients-10-01561"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotwal</surname><given-names>S.</given-names></name><name><surname>Jun</surname><given-names>M.</given-names></name><name><surname>Sullivan</surname><given-names>D.</given-names></name><name><surname>Perkovic</surname><given-names>V.</given-names></name><name><surname>Neal</surname><given-names>B.</given-names></name></person-group><article-title>Omega 3 fatty acids and cardiovascular outcomes: Systematic review and meta-analysis</article-title><source>Circ. Cardiovasc. Qual. Outcomes</source><year>2012</year><volume>5</volume><fpage>808</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.112.966168</pub-id><?supplied-pmid 23110790?><pub-id pub-id-type="pmid">23110790</pub-id></element-citation></ref><ref id="B138-nutrients-10-01561"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowdhury</surname><given-names>R.</given-names></name><name><surname>Stevens</surname><given-names>S.</given-names></name><name><surname>Gorman</surname><given-names>D.</given-names></name><name><surname>Pan</surname><given-names>A.</given-names></name><name><surname>Warnakula</surname><given-names>S.</given-names></name><name><surname>Chowdhury</surname><given-names>S.</given-names></name><name><surname>Ward</surname><given-names>H.</given-names></name><name><surname>Johnson</surname><given-names>L.</given-names></name><name><surname>Crowe</surname><given-names>F.</given-names></name><name><surname>Hu</surname><given-names>F.B.</given-names></name><etal/></person-group><article-title>Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: Systematic review and meta-analysis</article-title><source>BMJ</source><year>2012</year><volume>345</volume><fpage>e6698</fpage><pub-id pub-id-type="doi">10.1136/bmj.e6698</pub-id><?supplied-pmid 23112118?><pub-id pub-id-type="pmid">23112118</pub-id></element-citation></ref><ref id="B139-nutrients-10-01561"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestel</surname><given-names>P.</given-names></name><name><surname>Clifton</surname><given-names>P.</given-names></name><name><surname>Colquhoun</surname><given-names>D.</given-names></name><name><surname>Noakes</surname><given-names>M.</given-names></name><name><surname>Mori</surname><given-names>T.A.</given-names></name><name><surname>Sullivan</surname><given-names>D.</given-names></name><name><surname>Thomas</surname><given-names>B.</given-names></name></person-group><article-title>Indications for omega-3 long chain polyunsaturated fatty acid in the prevention and treatment of cardiovascular disease</article-title><source>Heart Lung Circ.</source><year>2015</year><volume>24</volume><fpage>769</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.hlc.2015.03.020</pub-id><?supplied-pmid 25936871?><pub-id pub-id-type="pmid">25936871</pub-id></element-citation></ref><ref id="B140-nutrients-10-01561"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>K.</given-names></name><name><surname>Rimm</surname><given-names>E.B.</given-names></name><name><surname>Merchant</surname><given-names>A.</given-names></name><name><surname>Rosner</surname><given-names>B.A.</given-names></name><name><surname>Stampfer</surname><given-names>M.J.</given-names></name><name><surname>Willet</surname><given-names>W.C.</given-names></name><name><surname>Ascherio</surname><given-names>A.</given-names></name></person-group><article-title>Fish consumption and risk of stroke in men</article-title><source>JAMA</source><year>2002</year><volume>288</volume><fpage>3130</fpage><lpage>3136</lpage><pub-id pub-id-type="doi">10.1001/jama.288.24.3130</pub-id><?supplied-pmid 12495393?><pub-id pub-id-type="pmid">12495393</pub-id></element-citation></ref><ref id="B141-nutrients-10-01561"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Harris</surname><given-names>W.S.</given-names></name><name><surname>Chung</surname><given-names>M.</given-names></name><name><surname>Lichtenstein</surname><given-names>A.H.</given-names></name><name><surname>Balk</surname><given-names>E.M.</given-names></name><name><surname>Kupelnick</surname><given-names>B.</given-names></name><name><surname>Jordan</surname><given-names>H.S.</given-names></name><name><surname>Lau</surname><given-names>J.</given-names></name></person-group><article-title>n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: A systematic review</article-title><source>Am. J. Clin. Nutr.</source><year>2006</year><volume>84</volume><fpage>5</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1093/ajcn/84.1.5</pub-id><?supplied-pmid 16825676?><pub-id pub-id-type="pmid">16825676</pub-id></element-citation></ref><ref id="B142-nutrients-10-01561"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myint</surname><given-names>P.K.</given-names></name><name><surname>Welch</surname><given-names>A.A.</given-names></name><name><surname>Bingham</surname><given-names>S.A.</given-names></name><name><surname>Luben</surname><given-names>R.N.</given-names></name><name><surname>Wareham</surname><given-names>N.J.</given-names></name><name><surname>Day</surname><given-names>N.E.</given-names></name><name><surname>Khaw</surname><given-names>K.T.</given-names></name></person-group><article-title>Habitual fish consumption and risk of incident stroke: The European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study</article-title><source>Public Health Nutr.</source><year>2006</year><volume>9</volume><fpage>882</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1017/PHN2006942</pub-id><?supplied-pmid 17010254?><pub-id pub-id-type="pmid">17010254</pub-id></element-citation></ref><ref id="B143-nutrients-10-01561"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozaffarian</surname><given-names>D.</given-names></name><name><surname>Longstreth</surname><given-names>W.T.</given-names><suffix>Jr.</suffix></name><name><surname>Lemaitre</surname><given-names>R.N.</given-names></name><name><surname>Manolio</surname><given-names>T.A.</given-names></name><name><surname>Kuller</surname><given-names>L.H.</given-names></name><name><surname>Burke</surname><given-names>G.L.</given-names></name><name><surname>Siscovick</surname><given-names>D.S.</given-names></name></person-group><article-title>Fish consumption and stroke risk in elderly individuals: The cardiovascular health study</article-title><source>Arch. Intern. Med.</source><year>2005</year><volume>165</volume><fpage>200</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1001/archinte.165.2.200</pub-id><?supplied-pmid 15668367?><pub-id pub-id-type="pmid">15668367</pub-id></element-citation></ref><ref id="B144-nutrients-10-01561"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yashodhara</surname><given-names>B.M.</given-names></name><name><surname>Umakanth</surname><given-names>S.</given-names></name><name><surname>Pappachan</surname><given-names>J.M.</given-names></name><name><surname>Bhat</surname><given-names>S.K.</given-names></name><name><surname>Kamath</surname><given-names>R.</given-names></name><name><surname>Choo</surname><given-names>B.H.</given-names></name></person-group><article-title>Omega-3 fatty acids: A comprehensive review of their role in health and disease</article-title><source>Postgrad. Med. J.</source><year>2009</year><volume>85</volume><fpage>84</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1136/pgmj.2008.073338</pub-id><?supplied-pmid 19329703?><pub-id pub-id-type="pmid">19329703</pub-id></element-citation></ref><ref id="B145-nutrients-10-01561"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bays</surname><given-names>H.E.</given-names></name></person-group><article-title>Safety considerations with omega-3 fatty acid therapy</article-title><source>Am. J. Cardiol.</source><year>2007</year><volume>99</volume><fpage>35C</fpage><lpage>43C</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2006.11.020</pub-id><?supplied-pmid 17368277?><pub-id pub-id-type="pmid">17368277</pub-id></element-citation></ref><ref id="B146-nutrients-10-01561"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>W.S.</given-names></name></person-group><article-title>Expert opinion: Omega-3 fatty acids and bleeding&#x02014;Cause for concern?</article-title><source>Am. J. Cardiol.</source><year>2007</year><volume>99</volume><fpage>44C</fpage><lpage>46C</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2006.11.021</pub-id><?supplied-pmid 17368278?><pub-id pub-id-type="pmid">17368278</pub-id></element-citation></ref><ref id="B147-nutrients-10-01561"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>P.D.</given-names></name><name><surname>Joy</surname><given-names>P.S.</given-names></name><name><surname>Nkonde</surname><given-names>C.</given-names></name><name><surname>Hessen</surname><given-names>S.E.</given-names></name><name><surname>Karalis</surname><given-names>D.G.</given-names></name></person-group><article-title>Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel&#x02014;versus&#x02014;aspirin + clopidogrel in patients with cardiovascular disease</article-title><source>Am. J. Cardiol.</source><year>2009</year><volume>104</volume><fpage>1052</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2009.05.055</pub-id><?supplied-pmid 19801023?><pub-id pub-id-type="pmid">19801023</pub-id></element-citation></ref><ref id="B148-nutrients-10-01561"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salisbury</surname><given-names>A.C.</given-names></name><name><surname>Harris</surname><given-names>W.S.</given-names></name><name><surname>Amin</surname><given-names>A.P.</given-names></name><name><surname>Reid</surname><given-names>K.J.</given-names></name><name><surname>James</surname><given-names>H.</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>J.H.</given-names><suffix>Jr.</suffix></name><name><surname>Spertus</surname><given-names>J.A.</given-names></name></person-group><article-title>Relation between red blood cell omega-3 fatty acid index and bleeding during acute myocardial infarction</article-title><source>Am. J. Cardiol.</source><year>2012</year><volume>109</volume><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2011.07.063</pub-id><?supplied-pmid 21944672?><pub-id pub-id-type="pmid">21944672</pub-id></element-citation></ref><ref id="B149-nutrients-10-01561"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covington</surname><given-names>M.B.</given-names></name></person-group><article-title>Omega-3 fatty acids</article-title><source>Am. Fam. Physician</source><year>2004</year><volume>70</volume><fpage>133</fpage><lpage>140</lpage><?supplied-pmid 15259529?><pub-id pub-id-type="pmid">15259529</pub-id></element-citation></ref><ref id="B150-nutrients-10-01561"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bays</surname><given-names>H.</given-names></name></person-group><article-title>Clinical overview of Omacor: A concentrated formulation of omega-3 polyunsaturated fatty acids</article-title><source>Am. J. Cardiol.</source><year>2006</year><volume>98</volume><fpage>71i</fpage><lpage>76i</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2005.12.029</pub-id><?supplied-pmid 16919519?><pub-id pub-id-type="pmid">16919519</pub-id></element-citation></ref><ref id="B151-nutrients-10-01561"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myhre</surname><given-names>A.M.</given-names></name><name><surname>Carlsen</surname><given-names>M.H.</given-names></name><name><surname>B&#x000f8;hn</surname><given-names>S.K.</given-names></name><name><surname>Wold</surname><given-names>H.L.</given-names></name><name><surname>Laake</surname><given-names>P.</given-names></name><name><surname>Blomhoff</surname><given-names>R.</given-names></name></person-group><article-title>Water-miscible, emulsified, and solid forms of retinol supplements are more toxic than oil-based preparations</article-title><source>Am. J. Clin. Nutr.</source><year>2003</year><volume>78</volume><fpage>1152</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1093/ajcn/78.6.1152</pub-id><?supplied-pmid 14668278?><pub-id pub-id-type="pmid">14668278</pub-id></element-citation></ref><ref id="B152-nutrients-10-01561"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Despres</surname><given-names>C.</given-names></name><name><surname>Beuter</surname><given-names>A.</given-names></name><name><surname>Richer</surname><given-names>F.</given-names></name><name><surname>Poitras</surname><given-names>K.</given-names></name><name><surname>Veilleux</surname><given-names>A.</given-names></name><name><surname>Ayotte</surname><given-names>P.</given-names></name><name><surname>Dewailly</surname><given-names>E.</given-names></name><name><surname>Saint-Amour</surname><given-names>D.</given-names></name><name><surname>Muckle</surname><given-names>G.</given-names></name></person-group><article-title>Neuromotor functions in Inuit preschool children exposed to Pb, PCBs, and Hg</article-title><source>Neurotoxicol. Teratol.</source><year>2005</year><volume>27</volume><fpage>245</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1016/j.ntt.2004.12.001</pub-id><?supplied-pmid 15734276?><pub-id pub-id-type="pmid">15734276</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="nutrients-10-01561-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Classification of long-chain fatty acids.</p></caption><graphic xlink:href="nutrients-10-01561-g001"/></fig><fig id="nutrients-10-01561-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Polyunsaturated fatty acids (PUFAs) subclasses: omega-6 and omega-3.</p></caption><graphic xlink:href="nutrients-10-01561-g002"/></fig></floats-group></article>